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Abstract 
In yeast, the synthesis of dNTPs progresses along two pathways, called the de novo pathway and 
the salvage pathway. Unpublished data from Claus Desler and Lene J. Rasmussen have shown that 
HeLa cells lacking mitochondrial DNA (0 cells) exhibit a significant lower pool of dNTPs than 
wild type cells. Assuming that Saccharomyces cerevisiae 0 cells also exhibit lowered dNTP pools, 
we have studied the expression of selected genes involved in nucleotide metabolism. As metabolic 
pathways are very similar in all eukaryotes, it is likely that the de novo and salvage pathways are 
conserved between yeast and HeLa cells, thus enabling us to draw parallels between expressions of 
genes in these cell lines. The main focus of this thesis is on the genes AAH1, ADE13, YNK1, BAS1, 
CDC21, URK1 and FCY2, due to their involvement in the nucleotide metabolism in S. cerevisiae, in 
different steps of the de novo and salvage pathway. The selection of genes was based on data 
provided in a genome wide gene array analysis of gene expression in wild type and 0 cells of S. 
cerevisiae. This data has kindly been made available to us by Lene J Rasmussen. We have studied 
the selected genes in order to determine if their differential expression in S. cereviciae 0 cells, 
compared to wild type cells, can explain a decrease in dNTP pools. 
We propose that the decreased dNTP pools observed in 0 cells can, at least in part, be explained by 
differential expression of the tree genes CDC21, AAH1 and ADE13, which are directly involved in 
the de novo and salvage pathways of nucleotide biosynthesis, as well as BAS1 which encodes for 
the general transcription factor Bas1p. 
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Introduction: 
Mitochondria are cell organelles present in the cytosol of all eukaryotic cells. Depending on the cell 
type variable numbers of mitochondria may be present. The primary function of mitochondria is to 
provide energy to the cell, in the form of ATP. The mitochondria are enclosed by two membranes, 
an outer and an inner membrane. In mitochondria, energy from the electron transport chain is used 
to produce a proton gradient across the inner membrane, which drives the oxidative 
phosphorylation of ADP to ATP1. ATP is the main energy source of the cell, therefore mutations in 
the mitochondrial DNA (mtDNA), affecting ATP production can be crucial and induce a variety of 
diseases2. The 16.5 kb circular human mitochondrial genome encodes for 13 proteins involved in 
the respiratory chain, as well as 22 tRNAs and 2 rRNAs3. As the expression of these genes is 
essential for a functional respiratory chain the preservation of the mitochondrial genome is critical 
for the ability of the cell to carry out oxidative phosphorylation. When mitochondrial DNA is 
damaged, induced mutations is often present in the chromosomal DNA as a result of a 
mitochondrial dysfunction4. 
It has been suggested that disruption of mtDNA can lead to cells with a mutator phenotype. Cells 
with a mutator phenotype have a high frequency of spontaneous mutations4,5. When the 
mitochondrial DNA is damaged, an increase of reactive oxygen species (ROS) is found in the cells, 
and these molecules can damage and induce mutations in both the mitochondrial and chromosomal 
DNA6. The production and degradation of ROS in the mitochondria is normally balanced. 
Instability in this balance can cause an increase of mutations in mitochondria. Mitochondrial DNA 
is more sensitive to ROS damage, due to the relative proximity of mtDNA to ROS producing sites, 
the lack of protective histones and the limited DNA repair system of the mitochondria. Due to the 
few non-coding regions in the mtDNA and the sensitivity to ROS damage, mutations in mtDNA are 
often observed in vital parts of the mitochondrial genome7-9.  
Bandy and Davison list several mitochondrial abnormalities commonly found in different cancer 
types. Apart from the oxidative phosphorylation these include; disturbed Ca2+ and K+ transport and 
impaired protein synthesis6. Indications have been made that in cancer cells the primary energy 
source is glycolysis and not ATP from oxidative phosporylation4. Mutations in the mitochondrial 
genome have frequently been observed in different cancer types8. Mutations that cause alterations in 
the mitochondrial genome are observed in tumours from bladder, kidney, breast, colon, pancreas, 
stomach, liver, lung, head and neck and in leukaemia and lymphoma4,7,10-13. The different types of 
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cancer related to mitochondrial mutations and mitochondrial dysfunctions support the theory that 
mtDNA could play a central role in carcinogenesis4,7.  
The extent of mtDNA alterations present in the mentioned cancer types is unknown but it has been 
shown that mitochondrial dysfunction is involved7.  
Diabetes and blindness can also be related to mitochondrial dysfunction14,15. In addition, it has been 
shown that there is an accumulation of mitochondrial mutations in older people compared to young 
people, this could be due to the longer exposure to ROS products15,16. 
It is clear from the previous section that mutations in the mtDNA can have a severe effect on the 
cell function. This combined with the fact that many cancer cells exhibit changes in the 
mitochondrial genome makes it interesting to investigate the possible effects of mitochondrial 
dysfunction.  
The nucleotide metabolism plays a key role in the cell cycle by supplying the building blocks for 
synthesis of DNA and RNA and for repair of DNA. To do this efficiently the different pools of 
nucleotides have to be strictly regulated in the cell, an imbalance in the pools could lead to 
inaccurate repair and replication errors17.  
In yeast, the synthesis of dNTPs progresses along two pathways, called the de novo and the salvage 
pathway, as such it would be reasonable to focus on these pathways in the study of the imbalanced 
dNTP pools. 
Unpublished data from Claus Desler and Lene J. Rasmussen have shown that HeLa cells with 
depletion of mtDNA (0) exhibit a significant lower pool of dNTPs. (See Appendix A) Assuming 
that S. cerevisiae 0 cells also exhibit lowered dNTP pools this could be a convenient general model 
for comparison with higher eukaryotes, as yeast is often used as a model organism for processes and 
functions in eukaryotic cells4. For this project results have generously been made available to us by 
Lene J. Rasmussen. The data provided is a genome wide gene array analysis of gene expression in 
wild type and 0 cells of S. cerevisiae18, based on measurements of mRNA levels. As metabolic 
pathways are very similar in eukaryotes, it can be assumed that these are conserved between HeLa 
and S. cereviciae. This enables us to transfer the observed decrease in dNTP pools in HeLa cells to 
a yeast model system. The similarity between the pathways in the two cell lines makes it likely that 
similar genes are involved in the pathways in both HeLa and S. cereviciae, so any differential 
expression of genes in yeast 0 cells could be similar in HeLa cells. 
In this thesis we have focused on several specific genes that influence different parts of nucleotide 
metabolism in S. cerevisiae. After thorough examination of the gene array data set, looking for 
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genes with a possible involvement in nucleotide biosynthesis, a short list of about 25 genes was 
generated, containing genes involved in nucleotide metabolism, with an up or down regulation more 
than 2 fold. The genes from this short list were then narrowed down to 7 genes, based on their 
placement in the pathways. The seven selected seven genes are AAH1, ADE13, YNK1, BAS1, 
CDC21, URK1 and FCY2; all involved in nucleotide metabolism at different steps of the de novo 
and salvage pathways of dNTPs.  
Although we are aware that not all mRNA is translated into protein, we will in this thesis regard a 
differential expression of genes (and thereby mRNA) as indicative of the protein translation. Thus, 
an up regulation of a gene will be regarded as causing an increased translation of protein. 
Aim: 
The aim of this thesis is to address the following questions: Why are the dNTP pools reduced in 0 
cells compared to the WT?  
Can low dNTP pools in 0 cells be explained by differential expression of genes placed along the de 
novo and the salvage pathway?  
This is based on the assumption that 0 cells from S. cerevisiae exhibit the same lowering in dNTP 
pools as it has been seen in HeLa cells. We also assume that it is the same genes that are affected in 
the two cell lines. Therefore we will be able to draw a parallel from yeast as our model organism to 
decreased dNTP pools in HeLa cells.  
Theoretical Background 
Yeast Strains 
Wild type 
This project centres around data sets gained from a gene array analysis carried out on 
Saccharomyces cerevisiae. Wild type yeast, as used in the gene array data, is a yeast strain which 
theoretically displays an intact genome, without mutations or other genetic defects. The yeast 
genome has 16 chromosomes, varying in size from 200-2200 kb19. In contrast to the genome of 
many higher eukaryotes, the yeast genome is very compact, with genes representing 72% of the 
genome19. In addition, yeast is a simple eukaryote, which makes it very useful as a model organism 
for more complex mammalian cells. Yeast is often used as a model for genetic analysis. The entire 
yeast genome has been sequenced, making it possible to trace changes in global gene expression, 
and to monitor mutations in the genome. It should be noted, however, that although the entire yeast 
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genome has been mapped, the function of many of the genes has not been determined19. The wild 
type cell line used in the gene array is called DL118, and is derived from the D273-10B cell line, a 
cell line often used as a wild type cell line in mitochondrial studies20. 
 

0
 cells 
Cells lacking mitochondrial DNA are called 0 cells. Mitochondrial DNA encodes for 13 proteins, 
all part of the respiratory chain3, and loss of mitochondrial DNA means that the cell can no longer 
produce ATP via the electron transport chain. 0 cells are, however able to proliferate despite the 
loss of mitochondrial function. These cells depend instead on glycolysis for ATP production, 
resulting in cells that, although slower growing, are viable. 0 cells are easily produced from wild 
type cells by treatment with ethidium bromide, and are often used for experiments involving 
mitochondrial function20. The method by which 0 cells are obtained is as follows: Wild type cells 
(DL1) are incubated at room temperature for 24 hours in Yeast Peptone Dextrose (YPD) medium 
containing 10 µg/ml ethidium bromide. This is done three times, after which the cells are diluted 
and streaked on YPD medium for single colonies. Colonies were then plated on Yeast Peptone 
Glycerol (YPG) medium, and 0 cells were selected as being unable to grow on YPG medium18. As 

0
 cells cannot derive energy from respiration (electron transport chain), these cells cannot grow on 
non-fermentable carbon sources such as glycerol20. 
The purines and pyrimidines 
As chemical compounds the nucleotides are quite simple structures. There are three main chemical 
components, deoxyribose sugar, phosphate and one of the four nitrogenous bases: adenine (A), 
guanine (G), cytosine (C) and thymine (T), whose structures are shown below21.  
  
 
 
 
Adenine Guanine Cytosine Thymine Uracil 
 
Adenine and guanine both have the double ring structure characteristic of the purines. Cytosine, 
thymine and uracil have a single ring structure and belong to the pyrimidines21. 
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Purine Nucleotide Pyrimidine nucleotide 
 
When the structure is composed of a pentose and a base it is known as a nucleoside, which can then 
be phosphorylated into a nucleotide. In RNA uracil (U) is present instead of thymine (T), and at the 
2’ carbon atom in the sugar there is a hydroxyl (OH) group instead of a hydrogen atom. In the table 
below the abbreviations for the nucleosides and nucleotides found in DNA and RNA is shown21. 
 
Base Nucleoside (= base + pentose) 
Nucleotide 
(= nucleotide + phosphate) 
 Ribonucleoside Deoxyribonucleoside NMP dNMP 
NDP 
dNDP 
NTP 
dNTP 
Purines      
Adenine Adenosine Deoxyadenosine AMP dAMP 
ADP 
dADP 
ATP 
dATP 
Guanine Guanosine Deoxyguanosine GMP dGMP 
GDP 
dGDP 
GTP 
dGTP 
Pyrimidines      
Cytosine Cytidine Deoxycytidine CMP dCMP 
CDP 
dCDP 
CTP 
dCTP 
Thymine Thymidine Deoxythymidine TMP dTMP 
TDP 
dTDP 
TTP 
dTTP 
Uracil Uridine Deoxyuridine UMP dUMP 
UDP 
dUDP 
UTP 
dUTP 
Table 1: Abbreviations for the nucleosides and nucleotides found in DNA and RNA (www.web-
books.com/mobio/)  
 
Nucleotides play an important role in many aspects of cellular metabolism, first and foremost as the 
building blocks of DNA and RNA. In DNA adenine always pairs with thymine and cytosine pairs 
with guanine. This pairing is one of the reasons for the helix shape of the DNA21. Stacking of the 
base pairs inside the DNA further contributes to the stability of the helix by excluding water 
molecules from the spaces between the base pairs, and thereby ensures conservation of the genetic 
material.  
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Another important role of nucleotides is their function as the energy source of the cells and donor of 
phosphoryl groups in metabolic transactions. 
 
Description of the pathways 
The synthesis of nucleotides is important for the DNA replication and repair and this can limit the 
rate of DNA synthesis in dividing cells22 
The biosynthesis of nucleotides can occur in two ways. In the de novo synthesis, nucleotides are 
metabolized from different precursors. De novo synthesis of nucleotides uses precursors like amino 
acids and CO2, NH2 and ribose. A general characteristic of the de novo pathway is that the end 
bases (adenine, cytosine, guanine and uracil) do not occur as free intermediates in the pathway. This 
means that the purines are built on the ribose and for the pyrimidines the pyrimidine rings are first 
synthesised and then attached to the ribose. This is different from the salvage pathway where the 
nitrogen bases of pyrimidines and purines are free intermediates22. 
The salvage pathway of nucleotides is a recycling process of free bases and nucleosides, which is 
released during the breakdown of nucleic acid. Recycling of nitrogen bases and nucleosides is an 
advantage for cells because it is more energy efficient than the de novo pathway22.  
The relation of de novo and salvage pathway is dependent of the cell type and the development 
stage. Activity of the de novo pathway is low in resting or fully differentiated cells, since these cells 
get their nucleotides mostly from the salvage pathway22.  
Proliferating cells are mainly provided with nucleic acid precursors from the de novo pathway. In 
growing cells this pathway is responsible for producing dNTPs for DNA synthesis and repair22.  
De novo pathway for pyrimidines 
A main property of the de novo pathway for pyrimidines is, that the pyrimidine ring is formed 
before it is attached to the ribose 5-phosphate. 
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Figure 1: De novo synthesis of pyrimidines. PRPP is indicated as ribose-P. E1-aspartate transcarbamoylase, E2-
dihydroorotase, E3-dihydroorotate dehydrogenase, E4-orotate phosphoribosyltransferase, E5-orotidylate 
decarboxylase, E6-UMP-kinase, E7-nucleoside diphosphokinase, E8-CTP synthetase23 
 
The first steps in forming the pyrimidine ring involve a multifunctional protein responsible for the 
first three reactions in Figure 1. 
The enzymes CPSase, ACTase and DHOase form the multifunctional protein CAD (carbamoyl-
phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) which is involved in 
forming dihydroorotate in mammalian cells22. CAD initiates pyrimidine biosynthesis in mammalian 
cells24, and is responsible for the same reactions in S. cerevisiae but here DHOase is not a part of 
the multifunctional protein25 
To form the structure of the pyrimidine ring, dihydroorotate is metabolized and the base orotate is 
produced and the pyrimidine ring is created before the 5-phospho-ribose-α-D-ribosyl-1-
pyrophosphate (PRPP) is added (see Figure 1. reaction E2-E4 )22. 
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Figure 2: Origins of the pyrimidine ring structure. C-2 
and N-3 atoms are provided by the 
carbamoylphosphate. N-1, C-4, C-5 and C-6 originate 
from aspartate26. 
 
The ring structure is supplied mainly by the aspartate and a smaller part is provided by 
carbamoylphosphate (see Figure 2). 
Decarboxylation of OMP produces UMP, which is then phosphorylated to UTP in two steps22(see 
Figure 1. reaction E5-E7). CTP is then formed from UTP by replacing the oxygen from the 
carboxyl group in UTP with an NH3 group from glutamine, with ATP providing the energy for this 
transfer. The enzyme involved is the amidotransferase CTP synthetase (Figure 1 reaction E8) which 
catalyses the addition of the NH3 to the pyrimidine ring and is activated by the purine GTP22.  
De novo pathway for purines 
To form the first ring in the purine structure, glutamine, glycine and formate are added to the ribose 
PRPP. (See Figure 3 reaction 1-5) 
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Figure 3: De novo biosynthesis of purine nucleotides. The synthesis starts at PRPP, which is indicated as ribose-
P. E1-PRPP amidotransferase, E2-GAR synthetase, E3-GAR transformylase, E4-FGAR amidotransferase, E5-
FGAM cyclase, E6-AIR carboxylase, E7-SAICAR synthetase, E8-SAICAR lyase, E9-AICAR transformylase, 
E10-IMPsynthetase23. 
 
The produced 5-aminoimidazole ribonucleotide (AIR) reacts with CO2 (see reaction 6 in Figure 3) 
to form N5-carboxyaminoimidazole ribonucleotide (N5 – CAIR). This step occurs only in some 
micro organisms, including yeast. This compound reacts to 5-amino-4-carboxy-amino imidazole 
ribonucleotide (CAIR)27 (see Figure 3 reaction 7). In other organisms CAIR is formed directly from 
AIR27.  
To complete the second ring of the purine structure, the nitrogen from aspartate and carbon from 
formate are needed27 (see Figure 3 reaction 8 and 9 and Figure 4) 
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After closing the second ring inosine monophosphate (IMP) is produced (see Figure 3), which is a 
precursor for the synthesis of both GMP and AMP28. (See Figure 3) 
 
Figure 4: Origin of the purine ring structure. N-1 
comes from aspartate, C-2 from formate which is 
supplied in the form of N10-formyltetrahydrofolate, N-
3 from glutamine, C-5, C-6 and N-7 from glycine, C-8 
from formate, N-9 also from glutamine1. 
 
 
 
The way to get the AMP from IMP is addition of aspartate and separation of fumarate (see reaction 
1 and 2 in Figure 5). AMP is then converted to ADP and finally to ATP by two phosphorylations28. 
A hydration of IMP and a conversion of glutamine to glutamic acid are required to form GMP. (See 
reaction 3 and 4 in Figure 5) GMP is then phosphorylated to GTP 28. 
 
Figure 5: Biosynthesis of the purine ribonucleotide monophosphates AMP and GMP from IMP. 1- 
adenylosuccinate synthetase, 2- adenylosuccinate lyase, 3- IMP dehydrogenase, 4- XMP-glutamine 
amidotransferase1. 
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Deoxyribonucleotide biosynthesis 
Most of the nucleotide triphosphates (NTPs)  are used in RNA, because the amount of RNA per cell 
is 5 to 10 times higher than of DNA29. There are two main points in the transformation of NTPs to 
dNTPs. Because of the chemical difference between ribose and deoxyribose the hydroxy group has 
to be displaced by hydrogen. The enzyme ribonucleotide reductase reduces the sugar of all four 
ribonucleotides (Figure 7) and uses ribonucleoside di- or triphosphates as substrates. (see equation 
below) 29. 
 
Figure 6: Reduction of ribonucleotides to deoxyribonucleotides: The enzyme ribonucleotide reductase catalyses 
the reduction of the hydroxyl group to hydrogen at C2’. 
 
During the reduction of the sugar, the hydroxyl group at the C-2 is replaced by a hydride ion this 
reduction involves a transport of free radicals29. 
Ribonucleotide reductase 
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Figure 7: Overview of 
deoxyribonucleotide 
biosynthesis23 
 
 
Uracil exists only in RNA and has to be converted to thymine, which occurs in DNA (Figure 7). 
The precursor of dTMP is dUMP, and as shown in Figure 7 there are two ways to produce dUMP. 
dUMP can be preformed from either CDP or UDP. Finally dUMP is converted to dTMP23.  
 
Degradation of purines and pyrimidines 
Intermediates from the degradation of nucleotides are essential for the salvage pathway.  
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Figure 8: Degradation of purine nucleotides. AMP and GMP is degradaded through several steps to form uric 
acid23. 
 
The degradation of AMP and IMP for recycling in the salvage pathway includes several steps for 
both AMP and IMP. Both compounds are catalysed through several steps by various nucleosidases 
and deaminases, before forming a common compound, xanthine. Xanthine is then oxidised into uric 
acid (see Figure 8), and in some animals uric acid is transformed to allantoin, allantoate and even 
urea23,26,30. 
The first step in degradation of CMP is to catabolize the monophosphate into the ribonucleoside 
cytidine (reaction not shown)23. 
The degradation of cytidine leads to the formation of uracil through uridine. Cytosine and 
deoxyuridine can also be transformed into uracil and degradaded by the same pathway26,30. From 
uracil, the pathway goes through several steps, ending with the formation of -alanine; ammonia 
and carbon dioxide (see Figure 9).  
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Figure 9: Degradation of the 
pyrimidine nucleoside cytidine. The 
end products are β-alanine, ammonia 
and CO2.23 
 
 
 
 
The degradation of TMP is very similar to that of CMP. TMP is dephosphorylated to thymidine, 
which is then converted to thymine. Thymine can then be recycled by the salvage pathway to form 
new pyrimidines. 
 
Salvage pathways 
Free pyrimidine and purine bases and nucleosides are released in cells as a result of nutrient uptake 
and degradation of DNA and RNA and are used afterwards to make nucleotides by a recycling 
process26. 
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In contrast to the de novo pathways the bases can occur as free intermediates during the synthesis 
for both purines and pyrimidines. They are added to the ribose PRPP to create the corresponding 
nucleotide. One example is when adenine reacts with PRPP to form AMP and diphosphate (PPi)26. 
 
The same reaction occurs for guanine and hypoxanthine, the deamination product of adenine. 
 
For the free pyrimidine bases the salvage pathway has a similar principle. Though cytosine cannot 
be added directly to PRPP it has to be converted to uracil which is then added to the ribose26.  
 
The interactions between pathways 
To get a clear overview of the selected genes influence on the de novo and salvage pathways for 
purines and pyrimidines, we have made an overview of the different pathways and the connections 
between them (see Appendix B). This overview illustrates where the different genes interact with 
the pathways, and makes it easier to estimate the combined effect of changes in gene products. 
The pathways are correlated in a number of different ways, for example some of the end products in 
the de novo pathway can supply the salvage pathway (See Appendix B). There is no exchange of 
intermediates between the pathways of purines or the pyrimidines. There is however contact 
between the pathways, PRPP for example is the donor of the ribose for both the purines and the 
pyrimidines (see Appendix B). Though it seems like the dCMP on the purine illustration is linked to 
the pathways of the pyrimidines it is not; the pathway in the top right corner of the purine 
illustration is a part of the de novo pathway producing the pyrimidine dCTP and dTTP (See 
Appendix B). The different intermediates from both the de novo and salvage pathway are accessible 
as substrates in the forming of dNTPs (See Appendix B). The main goal of this flow of different 
precursors is the production of the dNTPs. In our model we have made the assumption that the 
different pathways are accessible to each other, which implies that they have to be situated in the 
same compartment in the cell. There is however no clear identification to where the reactions are 
situated, though there are indications that some of the enzymes are located on or near the nucleus17. 
Recent studies by Pak-Phi Poon et al. have suggested that the enzymes involved in the syntheses of 
Adenine + PRPP Adenylat + PPi 
Guanine + PRPP Guanylat + PPi 
Hypoxanthine + PRPP Inosiat + PPi 
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dNTP interact in multi-enzyme complexes, though this has not been proved. Further they suggest 
that the dNTP synthesis occurs on the cytoplasmic side17.  
 
Data origin 
A large set of data were collected from a genechip® microarray analysis of wild type and 0 cells of 
S. cerevisiae (see section on yeast strains). The following section is included in order to provide 
background insight on the technique used to obtain the data on gene expression in 0 cells compared 
to wild type cells used in this thesis.  
Microarray analysis gives the opportunity to test thousands of genes at the same time and offers the 
opportunity for high through-put of samples as well.  
 
Figure 10: Picture of a microarray. The glass plate 
can be seen in the middle. (www.affymetrix.com) 
 
 
The method is to synthesize small oligos approximate 20 to 30 nucleotides in length on to a glass 
plate31 these oligos are called probes. (See Figure 11). 
Figure 11: Here the small squares with different 
colours are the different genes of interest. The 
highlighted little section is for clarification of how the 
probes are situated on the genechip®. 
(www.affymetrix.com) 
 
 
 
The probes are attached to the glass plate at the 5’ end; this insures that the added material (RNA or 
cDNA) can attach to the probe in the 3’ end. The Glass plate is about 1, 3 cm2 and can contain 
thousands of different probes. Each of the different probes represents one gene or a fragment of a 
gene. The material used for analysis is mRNA that is converted to cDNA (compliment DNA) by 
reverse transcriptase PCR.  
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The cDNA is denatured to separate the two strings so it can be labelled with biotin. The labelled 
cDNA is placed on the chip for the cDNA to attach to the different probes. After incubation, the 
biotinylated cDNA is washed and stained with streptavidin. 
 
Figure 12: Preparation of samples for analysis 
on the genechip®. (www.affymetrix.com). 
 
 
To measure the amount of biotinylated cDNA, laser light at a specific wavelength is directed on the 
glass plate (See Figure 13) with the stained cDNA. The probes with the labelled cDNA will emit 
light of a different colour, making identification of the cDNA attached to the glass plate possible 
(see Figure 13). This also makes it possible to see specific defined genes or SNPs (single nucleotide 
polymorphism). (All material is from www.affymetrix.com).  
Figure 13: This picture is similar to Figure 11, 
though this time the red squares are where the 
labelled cDNA has annealed to the probes. The 
other colours symbolises genes that have not been 
hybridized with labelled cDNA. 
(www.affymetrix.com) 
 
 
 
The genechip® used for the S. cerevisiae wild type and 0 cells contains probes for approximately 
5841 of the 5845 genes of S. cerevisiae (According to www.affymetrix.com).  
For this project, the gene array was carried out on both wild type and 0 cells of S. cerevisiae. The 
data is analysed and categorized according to the functional groups of the genes, and the difference 
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in the expression of genes in 0 cells compared to wild type cells were calculated (See Appendix C 
for a table of selected genes from the data set). 
Description of selected genes 
AAH1 
The protein encoded by AAH1 is 39.6 kDa (www.yeastgenome.org) and is located on chromosome 
14, (www.yeastgenome.org). The enzyme is called adenine deaminase (ADA), also referred to as 
adenine aminohydrolase. This enzyme is 347 amino acids long (www.yeastgenome.org) and is a 
part of the purine salvage pathway and nitrogen catabolism (See Appendix B, illustration of purine 
pathways). It catalyzes the conversion of adenine to hypoxanthine, the reaction is as follows: 
 
In the data set the AAH1 gene was up regulated 2.3 fold in the 0 cells compared to the WT strain of 
S. cerevisiae. This indicates a higher level of AAH1 mRNA present in the 0 cells compared to WT 
cells. Defects in the human gene for adenine deaminase are described to give severe combined 
immunodeficiency (SCID), which mostly affects lymphocytes32,33. Primarily there will be an 
accumulation of adenine which is used by the salvage pathway to produce AMP and ultimately lead 
to accumulation of dATP. This was studied by Arparia et al. which have shown that patients with 
SCID have an impaired degradation of adenine leading to accumulation of dATP and dGTP34. In 
further investigations of ADA deficient mice, Apasov et al. found that ADA deficiency mice also 
have a disruption in deoxynucleotide synthesis and a higher apoptosis level in T-lymphocytes35. 
This will lead to an accumulation of purine nucleotides as well. 
ADE13 
The gene ADE13 is located on chromosome 12 and the 54.5 kDa gene product codes for an enzyme 
482 amino acid long called adenylosuccinate lyase36 or adenylsuccinase (www.yeastgenome.org)37. 
According to the OMIM database at www.ncbi.nlm.nih.gov/entrez/ the two names are synonymous; 
therefore the name adenylosuccinate lyase will be used during the rest of this thesis. Although the 
Adenine hypoxanthine 
H2O NH3 
AAH1 
Adenine deaminase 
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OMIM database is restricted to mammalian genes, this nomenclature holds true in this case. This 
enzyme catalyzes two reactions in the de novo pathway, with different substrates, the 5’-
phosphorribosyl-4-(n-succinucarboxamide)-5-aminoimidazole (SAICAR) and Adenylosuccinate 
(S-Ado), both reactions with removal of fumarate. (See below and in Appendix B for illustration of 
purine pathways) 
 
Toth et al. suggest that because this enzyme can catalyse two different reactions it has the ability to 
add nitrogen in two different positions in AMP. To make these reactions proceed with two different 
substrates the enzyme has the ability to twist a single covalent bond 180° inside the active site38. 
The two enzymes are as shown above important in the metabolism of nucleotides and DNA 
replication. Alterations in adenylosuccinate lyase caused by mutations in ADE13 have been 
described to cause psychometric retardations and autism in humans by a not fully established 
mechanism38,39. It is suggested that accumulation of SAICAR and S-Ado in body fluids and 
especially in the cerebrospinal fluid are toxic for the neurons thereby leading to cerebral 
dysfunction38-40. The disease is known to be one of the only inherited deficiencies related to the de 
novo synthesis of purines39,40. According to the data set ADE13 was down regulated 4.3 fold in the 

0
 cells compared to the WT strain.  
YNK1 
YNK1 is located on chromosome 11, and encodes the nucleoside diphosphate kinase (NDPK), an 
enzyme with a molecular weight of 17.2 kDa (http://mips.gsf.de). It is involved in the salvage 
pathways of pyrimidine ribonucleotides and the de novo biosynthesis of pyrimidine 
deoxyribonucleotides (http://mips.gsf.de)  
ADE13 
Adenylosuccinate lyase 
Adenylo-succinate (S-Ado) AMP 
Fumarate 
And 
Fumarate 
ADE13 
Adenylosuccinate lyase 
5’-phosphorribosyl-4-(n-
succinucarboxamide)-5-
aminoimidazole (SAICAR) 
AICAR 
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The nucleoside diphosphate kinase catalyses the overall reaction1: 
 
As it appears from the reaction NDPK is able to catalyze the synthesis of all the nucleoside 
triphosphates. In the salvage pathways of pyrimidines the reaction is as follows: (See Appendix A) 
 
 In the de novo biosynthesis of pyrimidines, NDPK is responsible for the transfer of phosphate 
groups in three different reactions (http://mips.gsf.de). 
 
In our data set there is a down regulation of YNK1 by 2.4 fold in 0 cells, compared to wild type 
cells. As mentioned above NDPK has numerous functions in the cell. It is shown by Fukuchi et al. 
that S. cerevisiae with a defective YNK1 gene still has a production of 10% NDPK compared to a 
wild type41. This is unexpected on the basis that NDPK is needed to synthesize all of the dNTPs 
from the dNDPs. That we still se a production of NDPK could be because of the presence of 
another gene, coding for an enzyme able to complement the activity of YNK1 in the cell of S. 
cerevisiae41. Lu et al. have shown the existence of an enzyme called adenylate kinase, which 
ATP + NDP (dNDP) Mg
2+ 
ADP + NTP (dNTP) 
YNK1 
NDPK 
CDP CTP 
ADP ATP 
YNK1 
NDPK 
ATP ADP 
dUTP dUDP 
YNK1 
NDPK 
dTTP dTDP 
ATP ADP 
YNK1 
NDPK 
dCTP dCDP 
ATP ADP 
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complement the function of NDPK in synthesizing dNDP to dNTP42. The down regulation of YNK1 
could be response to a higher concentration of adenylate kinase. Lu et al. and Letvit et al. suggest 
that various mutations in the YNK1 gene do not affect the viability of the cells of Escherichia coli 
and yeast42,43. Letvit et al. also suggest that the main function of NDPK in  E. coli is not phosphoryl 
group transfer, but DNA cleavage and binding43. Since the human gene for NM23-H2 and YNK1 in 
E. coli has a certain homology, these findings are not unexpected as the NM23 gene in humans has 
been known to bind and cleave DNA. Further, E. coli cells with a deletion of the NDPK gene have 
an increased frequency of spontaneous mutations. This mutator phenotype could be rescued by 
transfecting the mutated cells with a plasmid caring a wild type NDPK gene. NDPK- cells also have 
an imbalance of intracellular dNTPs, most severely affected are the dCTP and dGTP pools, i.e. 20 
fold and 7 fold elevation respectively44. NM23 is well described as a tumour-suppressor gene and 
used as a prognostic marker in melanoma, breast and ovarian cancers where the gene is down 
regulated45.     
 
BAS1 
BAS1 is located on the chromosome 11 and encodes a general transcription factor Bas1p. 
(http://mips.gsf.de). The transcription factor is involved in the regulation of the purine biosynthesis 
pathways and has a molecular weight of 89.6 kDa (http://mips.gsf.de).  
Bas1p is together with Bas2p responsible for the transcription of the ADE genes which are involved 
in the de novo pathway.  
Adenine represses the synthesis of enzymes involved in all steps of the de novo purine 
synthesis23,46. Under adenine repressing conditions Bas1p and Bas2p is not able to form a complex, 
because of a structural change in Bas1p caused by adenine. This structural change in Bas1p makes 
the transcription of the ADE gene impossible (see Figure 14). When the adenine repression is 
unmasked the structure of Bas1p reverts to its original conformation, making it possible for Bas1p 
and Bas2p to form a complex together, and thereby starting the transcription of the ADE genes 
(illustrated in Figure 14)46,47.  
 
Differential expression of genes involved in nucleotide metabolism in 0 cells of Saccharomyces cerevisiae.  
Roskilde UniversitetsCenter 2004 
Jesper Schou,Søren Myhre Jensen, Maria Benn Hansen, Sophie Beyer 
 
 
23 
 
  
Figure 14: Suggested model for the complex formation of Bas1p and Bas2p, and their activation function. When 
adenine is present in the cell, it causes Bas1p to change conformation, making it unable to form a complex with 
Bas2p, thereby blocking transcription. When adenine is not present, Bas1p and Bas2p can form a complex 
together and enable transcription of ADE47. 
 
In our data set BAS1 was up regulated by 2.4 fold in the 0 cells compared to the WT strain. Since 
Bas1p is needed for optimal expression of enzymes involved in purine de novo synthesis, and 
transcription of this gene is repressed by adenine, an up regulation could be explained by low levels 
of adenine in the cell. 
 
CDC21 
The gene CDC21 (also known as TMP1), is located on Chromosome 15 (www.yeastgenome.org). It 
encodes for thymidylate synthase, a 35 kDa enzyme involved in the de novo pyrimidine metabolism 
pathway17. Pak-Phi Poon et al. suggests that the enzyme is located in the nuclear periphery and on 
the outer surface of the endoplasmic reticulum17. Thymidylate synthase is involved in one of the 
last steps in the formation of dTTP, as it facilitates the methylation of deoxyuracil monophosphate 
to deoxythymine monophosphate (dTMP), as shown below.  
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Thymidylate synthase activity is required, in order for the de novo synthesis of thymine to proceed. 
Thymidylate synthase exhibits high activity in growing cells, and low activity in quiescent cells48. 
This high activity means that proliferating cells, has elevated levels of thymidylate synthase49. 
Specifically, tumour cells exhibits very high levels of enzyme activity, which has made thymidylate 
synthase a possible target for chemotherapeutic agents49. Transcription of CDC21 has been 
demonstrated to occur almost exclusively during the late G1 and S phases of the cell cycle48,50,51, 
making thymidylate synthase one of the few proteins in yeast whose expression is cell cycle 
dependent50. Thymidylate synthase is present only in the G1/S phases of the cell cycle, and cells 
with a deficient CDC21 gene arrests in the S phase of cell division52. The reason why thymidylate 
synthase is only present in the cell during the G/S phase could be attributed to the high instability of 
this enzyme, causing it to degrade rapidly49.  
CDC21 is down regulated in 0 cells by 2.7 fold, compared to the wild type, which could cause a 
reduction in thymidylate activity in the cell, and consequently a reduction in dTTP formation. 
Indications have been made, that dTTP synthesis is critical for DNA synthesis, supported by 
observations that mutations in CDC21 increases occurrence of cells with - and 0 phenotype52. 
Gene expression of CDC21 at mRNA level has also been demonstrated to influence the prognosis 
of rectal cancer, as patients with high protein levels in tumour cells had a survival rate of 77.8% 
over a 10 year period, compared to 89.4% in patients with low thymidylate synthase levels53. 
 
URK1 
The gene URK1 is located on chromosome 14, and encodes for the enzyme uridine kinase, a 56.2 
kDa protein (www.yeastgenome.org). Uridine kinase is part of the salvage pathway of pyrimidine 
deoxyribonucleotides. and is capable of phosphorylating uridine and cytidine to UMP and CMP, 
respectively54,55. It is known both as uridine kinase and cytidine kinase, although it is the same 
enzyme. Uridine kinase catalyses the phosphorylation of uridine to UMP, and Cytidine to CMP54. 
The enzyme is not very specific in its requirement for phosphate donors, as almost any nucleotide 
CDC21 
Thymidylate synthase 
dTMP dUMP 
5,10-methylene-THF 7,8 dihydrofolate 
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triphosphate, including dNTPs, can be used as donors54. The only triphosphates that cannot be used 
as phosphor donors by uridine kinase are the end products CTP and UTP, which inhibits the 
reaction. 
 
 
Uridine kinase is the rate-limiting enzyme for the salvage pathway for uridine and cytosine54. The 
expression of URK1 is up regulated by 2.4 fold in 0 cells, compared to wild type cells. This up 
regulation could be interpreted as an attempt by the cell to compensate for low dNTP pools by 
increasing production of CTP and UMP. (See Appendix B) 
 
FCY2 
The gene FCY2 (also called BRA7) is located on chromosome 5 (www.genedb.org). It encodes for 
the purine-cytosine permease (PCP). This polytopic protein consists of 533 amino acids and has a 
molecular weight of 58.2 kDa.  
PCP is a secondary active transporter located in the plasma membrane of S. cerevisiae56. The 
integral plasma membrane protein transports adenine, hypoxanthine, guanine and cytosine into the 
cell, thus enabling it to accumulate these compounds. For all these ligands the carrier has the same 
efficiency of uptake and the same affinity of binding. Despite the structural difference between 
purines and pyrimidines, the binding site in PCP is the same for purines and cytosine56. The 
transport mechanism is a symport with protons in the ratio of 1:1. Thus the energy source is the 
electrochemical gradient of protons, which is created by the H+ -ATPase57  
URK1 
cytidine kinase 
NTP NDP 
CMP cytidin
URK1 
Uridine kinase 
UMP Uridin
 NTP NDP 
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Figure 15: Topological model of purine-cytosine permease PCP. The protein consists of nine transmembrane 
helices, an N-terminus at the intracellular side and the C-terminus at the extra cellular side. The N in grey circles 
at the fourth extra cellular loop is the residues N374 and N377. The other black letters in grey circles are T213 
and S272. The transmembrane segments TM5 and TM8 show the amino acid sequences. White letters in black 
circles are amino acids, which are likely involved in hydrogen bonds58. 
 
PCP consists of nine transmembrane α-helices with the C-terminus in the periplasmic and the N-
terminus in the cytoplasmic orientation. The N-terminus at the hydrophilic site consists of 98 
residues and the hydrophobic C-terminus has 48 residues. Several investigations have shown that 
the 374-377 segments could play a key role in the three-dimensional structure of PCP and the 
binding affinity of purines and cytosine. (Figure 15: 4th loop at the extra cellular side)58. The 374-
377 segment is essential for targeting and maintenance  of the whole protein and stabilising the 
tertiary structure important for the transport function.56.  
In the dataset it is shown that FCY2 is up regulated 2.1 fold in 0 cells compared to the wild type of 
S. cerevisiae.  
Similar proteins are observed in human and rat. hENT2 and rENT2 (equilibrate nucleoside 
transporter 2) are responsible for transport of hypoxanthine, adenine, guanine, uracil, and thymine. 
hENT2 is also able to transport cytosine. The transporters are integral membrane proteins with 11 
transmembrane helices59.  
Several mutations are described, which causes alterations in the segment 374-377 of PCP. Some of 
the mutations caused a lower transport activity of the protein. After deletion of 374-377 in one 
strain and the replacement of P376R in another strain, none of the strains showed any measurable 
transport activity. A strain with the replacement P376G did show a significantly decreased transport 
activity56. Ferreira et al. observed that the deletion of 374-377 (see Figure 15) caused a lower 
amount of PCP in the cell membrane in comparison to the total amount of protein in the cell56. 
Further, N374I, S272L and T213I replacement mutants also showed decreased transport activities 
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for the tested ligands, when compared to the wild type58. After these mutations the binding and 
transport activities for all ligands were not decreased by the same amount, resulting in an 
imbalanced uptake between different ligands56,58.  
Uptakes of nitrogen bases and nucleotides from the extra cellular side are a pre-condition for 
salvage pathways especial for cells, which are resting or fully differentiated22. 
  
Connection between the pathways and selected genes 
For each of the deoxyribonucleotide triphosphates dATP, dCTP, dTTP and dGTP the pathways 
involve multiple genes. Here we will describe which of our genes are involved in producing the 
specific dNTPs  
 
Deoxynucleotide Genes involved (regulation in 0 cells) 
dATP AAH1(2.3), ADE13(4.3 ), BAS1(2.4 ), 
FCY2(2.1) 
dGTP YNK1(2.4 ), ADE13(4.3 ), AAH1(2.3), 
FCY2(2.1) BAS1(2.4 ), 
dTTP CDC21 (2.7) YNK1(2.4 ), URK1(2.4), 
FCY2(2.1) 
dCTP 
 
URK1(2.4), YNK1(2.4 ), FCY2(2.1) 
Table 2: Genes involved in formation of deoxynucleotides: In the above table, each of the deoxynucleotides are 
listed, along with the genes which participates in their synthesis. The numbers and arrows in parenthesis indicate 
whether this gene is up regulated () or down regulated (), in 0 cells, compared with the wild type. 
 
As can be seen from the table above, the seven selected genes are distributed between the synthesis 
pathways of all four dNTPs. With the exception of YNK1 and FCY2, the genes are involved in 
either the synthesis of purines or pyrimidines. AAH1, BAS1 and ADE13 are all involved in the 
synthesis of dATP and dGTP. YNK1 participates in the synthesis of dGTP and both of the 
pyrimidines. For the pyrimidines, URK1 and CDC21 are involved in both dTTP and dCTP 
synthesis. As FCY2 encodes for a purine - cytidine transporter protein, it can be said to take part in 
the synthesis of all the dNTPs. This section is only provided as brief overviews of gene 
involvement. For placement of the gene products in the pathways, see Appendix A.  
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Discussion: 
The aim of this thesis has been to investigate if differential expression of genes involved in 
nucleotide metabolism could explain why dNTPs pools are decreased in 0 cells of S. cereviciae. In 
the following we will evaluate the selected genes individually with respect to their possible 
influences on dNTP pools.  
In our dataset the expression of CDC21 was down regulated 2.7 fold in 0 cells compared to WT. 
This means that the mRNA level is lower but this does not necessarily indicate a lower activity of 
the gene product, thymidylate synthase, although this is likely. If thymidylate synthase activity is 
decreased this would affect the formation of dTTPs, as thymidylate synthase occupies a rate 
limiting step in the dTTP synthesis. As mentioned in the introduction all dNTPs are required for 
DNA synthesis, so a reduction in dTTP synthesis will affect DNA synthesis. Greenwood et al. have 
shown that thymidylate synthase is only active in the S-phase in the cell cycle of proliferating cells, 
and it has been shown that cells lacking thymidylate synthase stop cell division in the S-
phase48,50,51. This supports the theory that an unbalanced dTTP synthesis is critical for DNA 
synthesis. Additionally, CDC21 mutants were shown by Guam et al. to cause an increase in the 
occurrence of cells with 0 phenotype60. Considering these facts, a down regulation in this gene 
could likely be a reason for the lower levels of dNTPs observed in 0 cells. 
Adenylosuccinate lyase, encoded by ADE13 is located at different positions in the de novo pathway. 
As shown by Race et al. psychomotor retardation and autism are linked to changes in the nucleotide 
metabolism by accumulating the substrates for adenylosuccinate lyase, SAICAR and S-Ado40. 
Because of the two different reactions ADE13 participates in it is likely to suggest that the 4.3 fold 
down regulation in the 0 cells compared with the WT cells we see in the dataset will contribute to a 
lowered pool of dATP and perhaps also dGTP since dGTP is formed from IMP.  
Another gene involved in dATP synthesis is AAH1, encoding for adenine deaminase (ADA). The 
lack of adenine degradation and increased nucleotide accumulation in ADA deficient cells, are due 
to inability to convert adenine to hypoxanthine by ADA34,35. An increase in the activity of ADA 
could lead to a smaller amount of adenine present in the cell, and therefore it could be suggested 
that the amount of dATP is reduced. In the dataset AAH1 is up regulated 2.3 fold in the 0 cells 
compared to the WT, these findings could contribute to the hypothesis that depletion of mtDNA can 
result in an imbalanced dNTP pool.  
As mentionedin the description of BAS1 and FCY2, the products from these genes are not directly 
involved in the purine and pyrimidine pathways. Since BAS1 and FCY2 code for a transcription 
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factor and a purine-cytosine transporter, respectively, an alternation of their function could have an 
influence on the lower dNTP levels. 
BAS1 is up regulated by 2.4 fold in our data set. This could indicate that the adenine level in the 0 
cells may be decreased18. As we see an up regulation of AAH1 it is likely that the adenine level in 0 
cells is low. However, as our dataset does not provide information on the transcription of the gene 
encoding for Bas2p, and complex formation between Bas1p and Bas2p is required for transcription 
of ADE genes47, we cannot say whether an increase in transcription takes place. An up regulation of 
BAS1 could occur when the de novo pathway of purines is limited by the transcription of the ADE 
genes. This could make up regulation of BAS1 an indication for lower purine nucleotide pool. Since 
BAS1p is a transcription factor for the ADE genes, which is involved in the de novo synthesis of 
purines, an up regulation could be a contributing factor in lowering dNTP pools.  
The transport function of PCP, encoded by FCY2 is important to provide precursors for the salvage 
pathway22, therefore changes in the activity of PCP, could affect the salvage pathway which is 
important for the cell as it provides nucleotides at a lower energy cost than the de novo pathway55. 
An explanation why we cannot see a direct effect of the up regulation could be a difference between 
the amount of the gene product in the complete cell and in the plasma membrane as mentioned in 
the gene description. The lower amount of PCP in the plasma membrane observed by Ferreira et al. 
is a possible evidence for a defect in the transport of the protein from the nucleus to the 
membrane56. The activity after this mutation could be comparable to our 0 cells. If this is true it 
could be a reason for the low dNTP pools observed in 0 cells. However, the data set we have used 
is based on gene expression, not protein activity or function, so this cannot be confirmed in this 
study. The up regulation of this gene could be a response by the cell to compensate for the 
decreased dNTP pools. The cell is trying to keep the balanced level of dNTPs and thus, the cell will 
produces more PCP to increase the transport activity and compensate for the lower pools. Based on 
this, the up regulation of FCY2 does not seem to be a probable reason for the low dNTP pools 
observed in 0 cells. 
In the description of YNK1 several independent studies have shown, that mutations in YNK1 did not 
have any effect on cell viability42,43. Cells with a mutation in YNK1 leading to dysfunction of the 
protein, still had a 10% production of NDPK compared to the wild type41. This could be explained 
by the presence of another gene, cable of complementing YNK142. Because YNK1 does not seem to 
be essential in the production of dNTPs, a 2.4 fold down regulation of this gene should not have a 
significant effect on dNTP production. This conclusion has to be made with reservations, because 
studies of E. coli NDPK- cells have shown a significant up regulation in the dCTP and dGTP pool44. 
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Importantly, the NDPK- cells have a complete deletion of the gene whereas the 0 cells only have a 
minor down regulation of the YNK1 gene and therefore not leading to any decrease of the dNTP 
pool in 0 cells. We can not see any evidence that a down regulation of YNK1 could significantly 
influence the balance of dNTP pools. This gene could instead be important for the development of 
the mutator phenotype described in 0 cells. NDPK- cells have an increased frequency of 
spontaneous mutations, and therefore our results could support the idea that 0 cells have a mutator 
phenotype45.  
In our data set, the expression of URK1, encoding for uridine kinase, was up regulated 2.4 fold in 0 
cells, compared to the WT strain. Uridine kinase occupies an important step in the salvage pathway, 
and as such, alterations in the expression of the URK1 gene could have an influence on the 
synthesis of nucleotides. This up regulation could indicate an increase in enzyme activity, which 
means that the cell is trying to produce more UMP and CMP. As we see low dNTP pools in 0 cells, 
this up regulation does not seem likely to explain these low dNTP pools. Rather, it can be seen as an 
attempt from the cell to respond to a reduced dNTP pool, by activating the salvage of nucleotides. 
With this in mind, the up regulation of URK1 does not present itself as a reason for low dNTP pools 
in 0 cells. 
 
Conclusion:  
The depletion of mtDNA seen in HeLa 0 cells has been shown to cause an imbalance in the dNTP 
pools. The aim of this thesis has been to investigate whether this imbalance could be explained by 
differential expression of genes involved in nucleotide metabolism. 
We propose that the decreased dNTP pools observed in 0 cells can, at least in part, be explained by 
differential expression of 3 genes directly involved in the de novo and salvage pathways of 
nucleotide biosynthesis. The 3 genes are: CDC21, encoding for thymidylate synthase, a rate 
limiting enzyme for dTTP formation; ADE13, encoding for adenylosuccinate lyase, active in AMP 
and IMP formation; AAH1, encoding for adenine deaminase, which catalyses the production of 
hypoxanthine from adenine. Another gene has also been considered likely to exert an effect on 
nucleotide metabolism, although it is not directly involved in the metabolic pathways. This gene is 
BAS1, coding of a transcription factor, Bas1p, involved in the transcription of ADE genes. Although 
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these genes have been considered to have an effect on nucleotide pools in the cell, but it is very 
likely that there are other contributing factors.  
 
Perspectives: 
The origin for this project was an observation of decreased dNTP pools in HeLa 0 cells. Based on 
this observation, we have assumed that dNTP pools would also be reduced in 0 cells of S. 
cereviciae. In this project we have used S. cereviciae as a model system, in order to explain why 
dNTP pools are decreased in 0 cells. To confirm that this underlying assumption holds true, it is 
necessary to measure dNTP pools in yeast 0 cells. The data set which is used in this project is 
based on the mRNA transcription levels in 0 cells of S. cereviciae, compared to wild type cells. As 
these doe not tell anything about protein levels, an analysis of this could provide additional 
information on whether an up or down regulation of a gene results in a corresponding change in 
protein levels. This could be determined by using western blot analysis.  
Several genes have been suggested as being likely to be involved in reduced dNTP pools in 0 cells. 
To confirm if these genes have an effect on the dNTP pools, cells with knockout in these specific 
genes, or combinations of genes, could be produced and dNTP pools measured. Another possible 
explanation for decreased dNTP pools in 0 cells could be found in the genes involved in the 
degradation of nucleotides, as the salvage pathway is dependent on degraded nucleotides. From this 
we have laid the foundation for further studies into these genes and their possible influence on 
dNTP pools. 
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Appendix A 
Unpublished data regarding imbalanced dNTP pools in HeLa 0 .
  
The different pathways are taken from 
www.yeastgenome.org and show both the 
de novo and salvage pathway of 
nucleotides. These pathways are connected 
so that the different end products in one 
pathway can feed into another pathway 
(shown by arrows). The yellow collared is 
the interacting substrates and the turquoise 
CTP 
YNK1 
See 
pathways 
of purines. 
CDP 
Pathways of pyrimidines 
CDC21 
UMP 
CDP YNK1 
dCMP 
dUMP YNK1 
dTMP 
YNK1 
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dTMP 
dUMP 
cytosine 
dCMP 
YNK1 
URK1 
URK1 cytosine 
UMP 
  
The different pathways are taken from www.yeastgenome.org and show 
both the de novo and salvage pathway of nucleotides. These pathways 
are connected so that the different end products in one pathway can feed 
into another pathway (shown by arrows). The yellow collared is the 
interacting substrates and the turquoise is our selected genes. To see the 
specific reactions look in the thesis under the relevant gene. 
Pathways of purines 
See pathways 
of pyrimidines 
Xanosine-5-phosphat 
Xanosine-5-phosphat 
GMP 
YNK1 
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Appendix B 
Illustrations of purine and pyrimidine metabolic pathways. 
  ii 
Measurement of whole-cell dNTP levels of the HeLa-WT and 
HeLa-Rho0 cell lines:  
 
Figure 16: A difference of whole-cell dNTP levels was measured between the HeLa-WT and 
HeLa-Rho0 cell lines. The difference was most prominent between the dTTP pools of the two 
cell lines where the pool was 10-fold decreased in Rho0 cells compared to the WT levels. 
However the dATP, dCTP and dGTP levels are also reduced compared to the WT levels, and 
this respectively 4.7, 5.1 and 2.8 fold.  
Cell cycle distrbution of the TK2+ and TK2- cell lines:  
The cell cycle distribution of the HeLa-WT and HeLa-Rho0 cell lines is measured to determine if 
the measured whole-cell pools are readily comparable 
 
0% 20% 40% 60% 80% 100%
HeLa-Rho0
HeLa-WT
G1 S G2
 G1 S G2 
HeLa-WT  54,47% 32,94% 12,60% 
HeLa-Rho0 65,99% 19,17% 14,84% 
 Figure 17: S-phase of the HeLa-Rho0 cells are 1.7 fold 
smaller compared to the s-phase of the HeLa-WT cells. 
Subsequently the G1-phase of the HeLa-Rho0 cells is 1.2 
fold larger than the same for HeLa-WT cells. The 
difference of cells in cell-cycle distribution is reflected in 
the growth rates of the two cell lines with the HeLa-Rho0 
cells having an slower growth rate than HeLa-WT cells. 
This is not surprising when considering that HeLa-Rho0 
cells solely depends on the glycolisis for ATP production. 
The lower fraction of HeLa-Rho0 cells in S-phase means 
that lower levels of cytosolic dNTP must be expected. 
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Appendix C 
Excerpts from gene array dataset.  
 CELLULAR ORGANIZATION     
     
  
1 
FUNCTIONAL CATEGORY - CELLULAR ORGANIZATION 
 
Probe Set 
Name 
 
ORF Gene name Synonym(s) FUNCTIONAL CATEGORY - 
CELLULAR ORGANIZATION 
OTHER FUNCTIONAL CATEGORIES Abs 
Call 
Fold 
Change 
Descriptions 
5108_at YGL089C MF 
(ALPHA)2 
MFAlpha2 extracellular/secretion proteins CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -pheromone response, mating-
type determination, sex-specific proteins  
P 3.4 alpha mating factor 
6021_f_at YDR461W MFA1  extracellular/secretion proteins CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -pheromone response, mating-
type determination, sex-specific proteins  / 
CELLULAR COMMUNICATION/SIGNAL 
TRANSDUCTION - intracellular 
communication; pheromone response 
generation; other pheromone response 
activities    
P ~ 3.4 a-factor mating pheromone 
precursor 
11262_s_at YAR071W PHO11  extracellular/secretion proteins  METABOLISM - phosphate metabolism; 
phosphate utilization 
P -6.0 Acid phosphatase, secreted  
9008_at YNL160W YGP1  extracellular/secretion proteins  CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response 
P -2.4 YGP1 encodes gp37, a glycoprotein 
synthesized in response to nutrient 
limitation which is homologous to 
the sporulation-specific SPS100 
gene  
10015_at YLR300W EXG1 BGL1 extracellular/secretion proteins  METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /CELL GROWTH, 
CELL DIVISION AND DNA SYNTHESIS - cell 
growth; pheromone response, mating-type 
determination, sex-specific proteins; 
sporulation and germination 
P -2.0 Exo-1,3-beta-glucanase  
7273_at YBR092C PHO3  extracellular/secretion proteins   METABOLISM - phosphate metabolism; 
phosphate utilization; metabolism of vitamins, 
cofactors, and prosthetic groups; utilization of 
vitamins, cofactors, and prosthetic groups 
P -25.6 Acid phosphatase, constitutive  
5303_at YFR049W YMR31  mitochondrial organization PROTEIN SYNTHESIS - ribosomal proteins  P -2.9 mitochondrial ribosomal protein 
(precursor) 
6503_at YDL004W ATP16 ATPDELTA; 
(ATP14) 
mitochondrial organization ENERGY - respiration/ TRANSPORT 
FACILITATION - transport ATPases / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS  - mitochondrial 
transport / IONIC HOMEOSTASIS - 
P -2.8 ATP synthase delta subunit 
 CELLULAR ORGANIZATION     
     
  
2 
homeostasis of cations; homeostasis of 
protons 
9930_at YLR395C COX8   mitochondrial organization ENERGY - respiration P -2.7 Cytochrome-c oxidase chain VIII 
7307_at YBR039W ATP3  mitochondrial organization ENERGY - respiration/TRANSPORT 
FACILITATION - transport 
ATPases/CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - mitochondrial 
transport/IONIC HOMEOSTASIS - 
homeostasis of cations 
P -2.7 gamma subunit of mitochondrial 
ATP synthase 
8428_at YOR136W IDH2  mitochondrial organization METABOLISM - C-compound and 
carbohydrate metabolism,C-compound and 
carbohydrate utilization/ENERGY - 
tricarboxylic-acid pathway/TRANSCRIPTION - 
other transcription activities 
P -2.7 NAD+-dependent isocitrate 
dehydrogenase 
9765_at YML120C  NDI1  mitochondrial organization ENERGY - respiration P -2.6 mitochondrial NADH ubiquinone 6 
oxidoreductase 
7407_at YBL045C COR1 QCR1 mitochondrial organization ENERGY - respiration P -2.6 44 kDa core protein of yeast 
coenzyme QH2 cytochrome c 
reductase 
10654_at YKL085W MDH1  mitochondrial organization METABOLISM - C-compound and 
carbohydrate metabolism,C-compound and 
carbohydrate utilization/ENERGY -
tricarboxylic-acid pathway 
P -2.6 mitochondrial malate 
dehydrogenase 
7727_at YPR020W ATP20  mitochondrial organization ENERGY - respiration P -2.5 hypothetical protein 
10290_at YLR038C COX12  mitochondrial organization ENERGY - respiration/ PROTEIN 
DESTINATION - assembly of protein 
complexes 
P -2.2 subunit VIb of cytochrome c oxidase 
5714_at YER014W HEM14  mitochondrial organization METABOLISM - metabolism of vitamins, 
cofactors, and prosthetic groups; biosynthesis 
of vitamins, cofactors, and prosthetic groups  
P -2.0 protoporphyrinogen oxidase 
3993_at Q0130? QLI1? (OLI2); 
(PHO2); 
ATP9 
mitochondrial organization ENERGY - respiration/ TRANSPORT 
FACILITATION  - transport ATPases / 
INTRACELLULAR TRANSPORT  - 
mitochondrial transport / IONIC 
HOMEOSTASIS - homeostasis of metal ions 
A ~-3.1 strong similarity to Yeast (S.uvarum) 
mitochondria RF2 gene and 
maturase-related hypothetical 
protein RF2 
4220_at YIL136W OM45  mitochondrial organization  P -8.7 45-kDa mitochondrial outer 
membrane protein 
6684_at YDL181W INH1  mitochondrial organization  ENERGY - other energy generation activities  P -7.2 ATPase inhibitor 
10390_at YLL041C SDH2 SDHB;SDH mitochondrial organization  ENERGY - tricarboxylic-acid pathway  P -6.3 Succinate dehydrogenase 
(ubiquinone) iron-sulfur protein 
subunit 
 CELLULAR ORGANIZATION     
     
  
3 
10725_at YKL148C SDH1 SDHA mitochondrial organization  METABOLISM -  C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ENERGY - 
tricarboxylic-acid pathway  
P -3.6 flavoprotein subunit of succinate 
dehydrogenase 
6531_at YDL067C COX9  mitochondrial organization  ENERGY - respiration/ PROTEIN 
DESTINATION  - assembly of protein 
complexes 
P -3.1 Subunit VIIa of cytochrome c 
oxidase 
10591_at YKL016C ATP7  mitochondrial organization  ENERGY - respiration/ TRANSPORT 
FACILITATION  - transport ATPases / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - mitochondrial 
transport / IONIC HOMEOSTASIS - 
homeostasis of cations; homeostasis of 
protons 
P -3.1 ATP synthase d subunit 
6074_at YDR377W ATP17  mitochondrial organization  ENERGY - respiration/ PROTEIN 
DESTINATION  - assembly of protein 
complexes 
P -2.9 ATP synthase subunit f 
8024_at YPL271W ATP15  mitochondrial organization  ENERGY - respiration/ TRANSPORT 
FACILITATION - transport ATPases/ 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS- mitochondrial 
transport/IONIC HOMEOSTASIS - 
homeostasis of cations, homeostasis of 
protons 
P -2.5 nuclear gene for ATP synthase 
epsilon subunit 
9350_at YMR256C COX7  mitochondrial organization  ENERGY - respiration / PROTEIN 
DESTINATION - assembly of protein 
complexes 
P -2.3 subunit VII of cytochrome c oxidase 
10731_at YKL142W MRP8  mitochondrial organization  PROTEIN SYNTHESIS - ribosomal proteins P -2.3 mitochondrial ribosomal protein 
6598_at YDL130W-
a? 
STF1? AIS2? mitochondrial organization  ENERGY - respiration P -2.2 ATPase stabilizing factor 
9291_at YML081C ATP18  mitochondrial organization  ENERGY -respiration  P -2.1 protein associated to the ATP 
synthase 
10723_at YKL150W MCR1  mitochondrial organization  ENERGY - respiration P -2.0 NADH-cytochrome b5 reductase 
9586_at YMR056C AAC1 (ANC1) mitochondrial organization  METABOLISM - nucleotide metabolism; 
nucleotide transport /TRANSPORT 
FACILITATION - purine and pyrimidine 
transporters /CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - mitochondrial 
transport 
P -2.0 mitochondrial ADP\/ATP 
translocator 
4003_s_at Q0045 COX1 OXI3 mitochondrial organization  ENERGY - respiration A ~-70.0 cytochrome-c oxidase subunit I 
Found forward in NC_001224 
 CELLULAR ORGANIZATION     
     
  
4 
between 21995 and 22246 with 
97.222222% identity. 
4980_at YGR008C STF2  mitochondrial organization   ENERGY - respiration/ CELLULAR 
BIOGENESIS - biogenesis of cell wall (cell 
envelope) 
P -4.3 ATPase stabilizing factor 
6279_at YDR178W SDH4  mitochondrial organization   METABOLISM -  C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ENERGY - 
tricarboxylic-acid pathway; respiration 
P -4.1 succinate dehydrogenase 
membrane anchor subunit 
4231_at YIL125W KGD1 OGD1 mitochondrial organization   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ ENERGY - 
tricarboxylic-acid pathway 
P -3.3 alpha-ketoglutarate dehydrogenase 
4246_at YIL155C GUT2  mitochondrial organization   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization 
P -3.1  glycerol-3-phosphate 
dehydrogenase, mitochondrial  
6339_at YDR148C KGD2  mitochondrial organization   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ ENERGY - 
tricarboxylic-acid pathway 
P -3.0 dihydrolipoyl transsuccinylase 
component of alpha-ketoglutarate 
dehydrogenase complex in 
mitochondria 
6172_at YDR298C ATP5 OSCP mitochondrial organization   ENERGY - respiration/ TRANSPORT 
FACILITATION - transport ATPases / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - mitochondrial 
transport /IONIC HOMEOSTASIS - 
homeostasis of cations; homeostasis of 
protons  
P -2.8 ATP synthase subunit 5\; oligomycin 
sensitivity-conferring protein 
10914_at YJR121W ATP2  mitochondrial organization   ENERGY - respiration/ TRANSPORT 
FACILITATION - transport ATPases / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - mitochondrial 
transport/ IONIC HOMEOSTASIS - 
homeostasis of cations;  homeostasis of 
protons 
P -2.4  F(1)F(0)-ATPase complex beta 
subunit, mitochondrial  
11145_at YJL102W MEF2  mitochondrial organization   PROTEIN SYNTHESIS - translation P -2.3 mitochondrial elongation factor G-
like protein 
4197_at YIL114C POR2  mitochondrial organization   CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - mitochondrial 
transport /TRANSPORT FACILITATION - 
channels/pores; ion channels  
P 2.1 voltage dependent anion channel 
(YVDAC2) 
3959_at Q0085 or 
(Q0230?) 
ATP6 OLI2;OLI4;PH
O1 
mitochondrial organization   ENERGY - respiration/ TRANSPORT 
FACILITATION - transport ATPases / 
A ~-181.9  F1F0-ATPase complex, FO A 
subunit  Found forward in 
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INTRACELLULAR TRANSPORT - 
mitochondrial transport /IONIC 
HOMEOSTASIS - homeostasis of metal ions  
NC_001224 between 28487 and 
29266 with 97.564103% identity. 
3976_at Q0130 OLI1 (OLI2);(PHO2
);ATP9 
mitochondrial organization   ENERGY - respiration/ TRANSPORT 
FACILITATION  - transport ATPases/ 
INTRACELLULAR TRANSPORT - 
mitochondrial transport/ IONIC 
HOMEOSTASIS - homeostasis of metal ions  
A ~-402.9  F1F0-ATPase complex, F0 subunit 
9  Found forward in NC_001224 
between 46723 and 46953 with 
100% identity. 
8849_at YNR001C CIT1 LYS6; GLU3 mitochondrial organization    METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ ENERGY - 
tricarboxylic-acid pathway 
P -4.3 citrate synthase. Nuclear encoded 
mitochondrial protein. 
10010_at YLR295C ATP14  mitochondrial organization    ENERGY - respiration/ TRANSPORT 
FACILITATION - transport ATPases / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS  - mitochondrial 
transport / IONIC HOMEOSTASIS - 
homeostasis of cations; homeostasis of 
protons 
P -2.9 ATP synthase subunit h 
8033_at YPL262W FUM1  mitochondrial organization; 
organization of cytoplasm 
ENERGY -tricarboxylic-acid pathway  P -2.6 mitochondrial and cytoplasmic 
fumarase (fumarate hydralase) 
8546_at YOR028C CIN5 (SDS15); 
(YAP4);HAL6 
nuclear organization CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -cell cycle control and mitosis 
/TRANSCRIPTION - mRNA transcription, 
mRNA synthesis, transcriptional control 
P -2.7  bZIP protein, can activate 
transcription from a promoter 
containing a Yap recognition site  
8151_s_at YOR074C  CDC21 TMP1 nuclear organization METABOLISM -nucleotide metabolism, 
deoxyribonucleotide metabolism 
P -2.7 Thymidylate synthase 
10528_at YKR056W RNC1 (NUD1); 
NUC2 
nuclear organization CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -recombination and DNA repair 
/CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - DNA repair    
P 2.1 endo-exonuclease yNucR 
4447_at YHR066W SSF1  nuclear organization CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -pheromone response, mating-
type determination; sex-specific proteins  
P 2.6 homologous to Ssf2p 
6813_at YCR072C   nuclear organization P 2.8 regulatory protein 
7266_at YBR088C POL30  nuclear organization  CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -DNA synthesis and replication; 
recombination and DNA repair   
P -2.2  profilerating cell nuclear antigen 
(PCNA)\; accessory factor for DNA 
polymerase delta, mRNA increases 
in G1, peaks in S in mitosis, and 
increases prior to DNA synthesis in 
meiosis  
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9493_at YMR139W RIM11 GSK3; MDS1 nuclear organization  CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -meiosis /TRANSCRIPTION - 
mRNA transcription; mRNA synthesis; 
transcriptional control /   
P -2.1  Serine\/threonine protein kinase, 
phosphorylates the mitotic activator 
IME1  
11327_at YAR007C RFA1 BUF2; 
FUN3;(RPA1) 
nuclear organization  CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -pheromone response, mating-
type determination, sex-specific proteins; DNA 
synthesis and replication; recombination and 
DNA repair CELLULAR ORGANIZATION - 
nuclear organization    
P -2.1  69 kDa subunit of the heterotrimeric 
RPA (RF-A) single-stranded DNA 
binding protein, binds URS1 and 
CAR1  
8342_at YOR230W WTM1  nuclear organization  TRANSCRIPTION - other transcription 
activities 
P -2.1 Transcriptional modulator 
10769_at YKL193C SDS22 EGP1 nuclear organization  CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -cell cycle control and mitosis/ 
PROTEIN DESTINATION - protein 
modification   
P -2.0 Interacts with and may be a positive 
regulator of GLC7 which encodes 
type1 protein phosphatase 
9683_at YML027W YOX1  nuclear organization  TRANSCRIPTION - other transcription 
activities 
P -2.0 Homeobox-domain containing 
protein 
6923_at YCL054W SPB1  nuclear organization  TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
PROTEIN SYNTHESIS - other protein-
synthesis activities    
P 2.0 Methyltransferase 
10335_at YLL008W DRS1  nuclear organization  PROTEIN DESTINATION - assembly of 
protein complexes /TRANSCRIPTION - rRNA 
transcription; rRNA processing   
P 3.1 putative ATP dependent RNA 
helicase 
7112_at YBR247C ENP1 MEG1 nuclear organization  PROTEIN DESTINATION - protein 
modification 
P 3.7 Putative 57 kDa protein with an 
apparent MW of 70 kDa by SDS-
PAGE 
6348_at YDR113C PDS1  nuclear organization   CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -cell cycle control and mitosis; 
cell cycle check point proteins  
P -2.8 42-kDa nuclear protein 
10332_at YLL011W SOF1  nuclear organization   TRANSCRIPTION - rRNA transcription; rRNA 
processing 
P 2.9 56 kDa nucleolar snRNP protein 
that shows homology to beta 
subunits of G-proteins and the 
splicing factor Prp4 
9378_at YMR239C RNT1  nuclear organization   TRANSCRIPTION - rRNA transcription; rRNA 
processing 
P 3.1 Ribonuclease III 
6436_at YDR021W FAL1  nuclear organization   TRANSCRIPTION - rRNA transcription; rRNA 
processing 
P 3.7  DEAD-box protein, putative RNA 
helicase  
6273_at YDR216W ADR1  nuclear organization    METABOLISM - C-compound and 
carbohydrate metabolism; regulation of C-
compound and carbohydrate utilization 
P -5.8 positive transcriptional regulator of 
ADH2 and peroxisomal protein 
genes 
 CELLULAR ORGANIZATION     
     
  
7 
/TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control   
11101_at YJL056C ZAP1  nuclear organization    TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control  
P -4.1 Metalloregulatory protein involved in 
zinc-responsive transcriptional 
regulation 
11144_at YJL103C   nuclear organization    TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control  
P -3.4 putative regulatory protein 
7261_at YBR083W TEC1 ROC1 nuclear organization    CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS - budding, cell polarity and 
filament formation/TRANSCRIPTION - mRNA 
transcription; mRNA synthesis; transcriptional 
control   
P 2.0  transcription factor of the 
TEA\/ATTS DNA-binding domain 
family, regulator of Ty1 expression  
4542_at YHL020C OPI1  nuclear organization    METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-acid and 
isoprenoid biosynthesis /TRANSCRIPTION - 
mRNA transcription; mRNA synthesis; 
transcriptional control  
P 2.0 negative regulator of phospholipid 
biosynthesis 
9667_at YML043C RRN11  nuclear organization    TRANSCRIPTION - rRNA transcription; rRNA 
synthesis  
P 3.8  Component of rDNA transcription 
factor CF, which also contains 
Rrn6p and Rrn7p, which is required 
for rDNA transcription by RNA 
polymerase I  
7398_at YBL054W   nuclear organization    TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control  
P 3.8 Homolog to myb transforming 
proteins 
7685_at YPR065W ROX1 REO1 nuclear organization    METABOLISM - metabolism of vitamins, 
cofactors, and prosthetic groups 
/TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control 
P 6.1  site-specific DNA binding protein, 
repressor  
9329_at YMR280C CAT8 DIL1; (MSP8) nuclear organization    METABOLISM - C-compound and 
carbohydrate metabolism; regulation of C-
compound and carbohydrate utilization / 
ENERGY - glycolysis and gluconeogenesis / 
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control 
A ~-3.0 Zinc-cluster protein involved in 
activating gluconeogenic genes\; 
related to Gal4p 
5409_at YFL021W GAT1 NIL1 nuclear organization     METABOLISM - nitrogen and sulphur 
metabolism; regulation of nitrogen and sulphur 
utilization /TRANSCRIPTION - mRNA 
transcription; mRNA synthesis; transcriptional 
control 
P -2.1 transcriptional activator with GATA-
1-type Zn finger DNA-binding motif 
6358_at YDR123C INO2 (SCS1); DIE1 nuclear organization     METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-acid and 
isoprenoid biosynthesis /TRANSCRIPTION - 
P 5.6 helix-loop-helix protein 
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mRNA transcription; mRNA synthesis; 
transcriptional control 
11323_at YAL001C TFC3 TSV115; 
FUN24 
nuclear organization      TRANSCRIPTION - rRNA transcription; rRNA 
synthesis; tRNA transcription; tRNA synthesis 
P ~-3.4 transcription factor tau (TFIIIC) 
subunit 138 
7767_at YPL031C PHO85  nuclear organization       METABOLISM - phosphate metabolism; 
regulation of phosphate utilization; C-
compound and carbohydrate metabolism; 
regulation of C-compound and carbohydrate 
utilization / ENERGY - metabolism of energy 
reserves (glycogen, trehalose) / CELL 
GROWTH, CELL DIVISION AND DNA 
SYNTHESIS - cell cycle control and mitosis 
/TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control  
P -2.1  negative transcriptional regulator, 
protein kinase homolog  
10480_at YKR099W BAS1  nuclear organization       METABOLISM - amino-acid metabolism; 
regulation of amino-acid metabolism;nucleotide 
metabolism; regulation of nucleotide 
metabolism /TRANSCRIPTION - mRNA 
transcription; mRNA synthesis; transcriptional 
control 
P 2.4 Transcription factor regulating basal 
and induced activity of histidine and 
adenine biosynthesis genes 
8850_at YOL012C HTZ1 HTA3 nuclear organization, organization of chromosome structure P -2.7 Putative transmembrane protein 
8140_at YOR386W PHR1  nuclear organization; 
mitochondrial organization  
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - DNA repair   
P -3.8 photolyase 
7898_at YPL127C HHO1  nuclear organization; organization of chromosome structure   P -2.3 histone H1 
7274_at YBR093C PHO5  organization of cell wall  METABOLISM - phosphate metabolism; 
phosphate utilization; metabolism of vitamins, 
cofactors, and prosthetic groups; utilization of 
vitamins, cofactors, and prosthetic groups 
P -21.4  Acid phosphatase, repressible  
10756_at YKL163W PIR3  organization of cell wall  CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response  
P -5.6 Protein containing tandem internal 
repeats 
5429_at YFL051C   organization of cell wall  P 5.1 putative pseudogene 
10483_at YKR102W FLO10  organization of cell wall; extracellular/secretion proteins   P 2.0 Protein with similarity to flocculation 
protein Flo1p 
4100_at YIR019C MUC1 STA4; DEX2; 
MAL5; STA1; 
FLO11 
organization of cell wall; 
extracellular/secretion proteins  
METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization  
P 7.2 cell surface flocculin with structure 
similar to serine\/threonine-rich GPI-
anchored cell wall proteins 
7994_at YPL255W BBP1  organization of centrosome CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -budding, cell polarity and 
filament formation; meiosis; cell cycle control 
and mitosis; cytokinesis    
A -2.4 Involved in mitotic cell cycle and 
meiosis 
7901_at YPL124W NIP29 SPC29 organization of centrosome CELLULAR TRANSPORT AND P -2.4 Nuclear import protein 
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TRANSPORTMECHANISMS - nuclear 
transport  
5718_at YER018C SPC25  organization of centrosome  P -2.0 component of spindle pole 
10478_at YKR097W PCK1 PEPC; PPC1; 
JPM2 
organization of cytoplasm METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization / ENERGY - glycolysis 
and gluconeogenesis  
P -9.7 phosphoenolpyruvate 
carboxylkinase 
7217_at YBR126C TPS1 GGS1; CIF1; 
TSS1; FDP1; 
BYP1; GLC6 
organization of cytoplasm METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization; regulation of C-
compound and carbohydrate utilization / 
ENERGY - metabolism of energy reserves 
(glycogen,  trehalose) /  CELL RESCUE, 
DEFENSE, CELL DEATH AND AGEING  - 
stress response 
P -2.9 56 kD synthase subunit of 
trehalose-6-phosphate 
synthase\/phosphatase complex 
6937_at YCL040W GLK1                                                  
SCAN11 
organization of cytoplasm METABOLISM - C-compound and 
carbohydrate metabolism,C-compound and 
carbohydrate utilization/ENERGY - glycolysis 
and gluconeogenesis 
P -2.7 Glucokinase 
6462_at YDR001C NTH1 NTH;YD8119.
07 
organization of cytoplasm METABOLISM - C-compound and 
carbohydrate metabolism,C-compound and 
carbohydrate utilization/ENERGY -metabolism 
of energy reserves (glycogen, trehalose) 
P -2.7  neutral trehalase (alpha,alpha-
trehalase)  
9355_at YMR261C TPS3   organization of cytoplasm METABOLISM - C-compound and 
carbohydrate metabolism,C-compound and 
carbohydrate utilization/ENERGY -metabolism 
of energy reserves (glycogen, trehalose) 
P -2.6 115 kD regulatory subunit of 
trehalose-6-phosphate 
synthase\/phosphatase complex 
11153_at YJL141C YAK1  organization of cytoplasm CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -cell cycle control and mitosis  
P -2.5 Serine-threonine protein kinase 
6843_at YCR057C PWP2  organization of cytoplasm CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -budding, cell polarity and 
filament formation; cytokinesis     
P 2.2 regulatory protein 
4483_s_at YHR053C CUP1-1 (CUP1); 
(MTH1); 
CUP1A 
organization of cytoplasm CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - detoxificaton   
P 2.5 copper-binding metallothionein 
9743_at YML100W TSL1  organization of cytoplasm  METABOLISM - C-compound and 
carbohydrate metabolism;C-compound and 
carbohydrate utilization /ENERGY - 
metabolism of energy reserves (glycogen, 
trehalose) 
P -16.5 123 kD regulatory subunit of 
trehalose-6-phosphate 
synthase\/phosphatase complex\; 
homologous to TPS3 gene product 
7392_at YBL015W ACH1  organization of cytoplasm  METABOLISM - lipid, fatty-acid and isoprenoid P -7.1 acetyl CoA hydrolase 
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metabolism; regulation of lipid, fatty-acid and 
isoprenoid biosynthesis /CELL GROWTH, 
CELL DIVISION AND DNA SYNTHESIS - 
sporulation and germination 
9958_at YLR377C FBP1  organization of cytoplasm  METABOLISM -  C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ENERGY - glycolysis 
and gluconeogenesis   
A -3.9  fructose-1,6-bisphosphatase  
5356_at YFR014C CMK1  organization of cytoplasm  CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -cell growth /CELLULAR 
COMMUNICATION/SIGNAL TRANSDUCTION 
- intracellular communication; other signal-
transduction activities  
P -3.3 Calmodulin-dependent protein 
kinase 
10629_at YKL067W YNK1 YNK;NDK1 organization of cytoplasm  METABOLISM - nucleotide metabolism; other 
nucleotide-metabolism activities 
P -2.4 Nucleoside diphosphate kinase 
7993_at YPL256C CLN2 PSC2 organization of cytoplasm  CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -budding, cell polarity and 
filament formation; pheromone response, 
mating-type determination, sex-specific 
proteins; DNA synthesis and replication; cell 
cycle control and mitosis  
P -2.3 G(sub)1 cyclin 
5588_at YER103W SSA4  organization of cytoplasm  CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response  
P 2.0 member of 70 kDa heat shock 
protein family 
8955_at YNL077W   organization of cytoplasm  PROTEIN DESTINATION - protein folding and 
stabilization 
P 2.3 similarity to dnaJ protein homolog 
YDJ1 
5357_at YFR015C GSY1  organization of cytoplasm   METABOLISM -C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ ENERGY - 
metabolism of energy reserves 
(glycogen,trehalose) 
P -30.4 Glycogen synthase (UDP-gluocse--
starch glucosyltransferase) 
5735_at YEL011W GLC3  organization of cytoplasm   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ENERGY - metabolism 
of energy reserves (glycogen, trehalose)  
P -8.3  1,4-glucan-6-(1,4-glucano)-
transferase  
9547_at YMR105C PGM2 GAL5 organization of cytoplasm   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /ENERGY - 
metabolism of energy reserves (glycogen, 
trehalose) 
P -8.3 Phosphoglucomutase 
4924_at YGR088W CTT1  organization of cytoplasm   CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response; detoxificaton  
P -5.9 cytoplasmic catalase T 
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10360_at YLL026W HSP104  organization of cytoplasm   CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response / PROTEIN 
DESTINATION - other protein-destination 
activities  
P -3.3 heat shock protein 104 
5307_at YFR053C HXK1 HKA organization of cytoplasm   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization/ ENERGY - glycolysis 
and gluconeogenesis 
P -2.1 Hexokinase I (PI) (also called 
Hexokinase A) 
5702_at YER003C PMI40  organization of cytoplasm   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization 
P -2.1 mannose-6-phosphate isomerase 
7961_f_at YPL198W RPL7B YL8B; 
(RPL6B) 
organization of cytoplasm   PROTEIN SYNTHESIS - ribosomal proteins P 2.0 Ribosomal protein L7B (L6B) (rp11) 
(YL8) 
7869_at YPL111W CAR1  organization of cytoplasm   METABOLISM - amino-acid metabolism; 
amino-acid degradation (catabolism); nitrogen 
and sulphur metabolism; regulation of nitrogen 
and sulphur utilization 
P 2.1 arginase 
10051_at YLR291C GCD7  organization of cytoplasm   PROTEIN SYNTHESIS - translation P 2.2  translation initiation factor eIF2b, 43 
kDa subunit\; negative regulator of 
GCN4 expression  
7604_at YPR160W GPH1  organization of cytoplasm    METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /ENERGY - 
metabolism of energy reserves (glycogen, 
trehalose) 
P -10.9 Glycogen phosphorylase 
5645_at YER072W VTC1 NRF1 organization of cytoplasm    SIGNAL TRANSDUCTION - intracellular 
communication; other signal-transduction 
activities/ CELLULAR COMMUNICATION 
P -4.3  Homolog of S. pombe Nrf1 (97\% 
identical in predicted amino acid 
sequence), which was identified in a 
genetic screen by its ability to 
reverse the Cdc42p suppression of 
a cdc24-4ts mutant  
8880_at YNL015W PB12  organization of cytoplasm    PROTEIN DESTINATION - proteolysis P -4.2 Proteinase inhibitor I2B (PBI2), that 
inhibits protease Prb1p (yscB)  
6192_at YDR272W GLO2  organization of cytoplasm    METABOLISM - amino-acid metabolism; 
amino-acid degradation (catabolism) 
P -2.0 Cytoplasmic glyoxylase-II 
10753_at YKL166C TPK3 PKA3 organization of cytoplasm    CELLULAR COMMUNICATION/SIGNAL 
TRANSDUCTION - intracellular 
communication; other signal-transduction 
activities / TRANSCRIPTION - mRNA 
transcription; mRNA synthesis; transcriptional 
control 
P 2.1 cAMP-dependent protein kinase 
catalytic subunit 
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8380_at YOR178C GAC1  organization of cytoplasm     METABOLISM - C-compound and 
carbohydrate metabolism; regulation of C-
compound and carbohydrate utilization 
/ENERGY - metabolism of energy reserves 
(glycogen, trehalose) 
P -4.8 Regulatory subunit for Glc7p 
8593_at YOL058W ARG1 ARG10 organization of cytoplasm     METABOLISM - amino-acid metabolism; 
amino-acid biosynthesis; nitrogen and sulphur 
metabolism; nitrogen and sulphur utilization 
P -2.1 arginosuccinate synthetase 
10019_at YLR304C ACO1 GLU1 organization of cytoplasm; 
mitochondrial organization   
METABOLISM -  C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /ENERGY - 
tricarboxylic-acid pathway; glyoxylate cycle  
P -4.8  Aconitase, mitochondrial  
6398_at YDR074W TPS2 HOG2; PFK3 organization of cytoplasm; 
mitochondrial organization   
METABOLISM -  C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /ENERGY - 
metabolism of energy reserves (glycogen, 
trehalose) / CELL RESCUE, DEFENSE, CELL 
DEATH AND AGEING - stress response  
P -3.9 Trehalose-6-phosphate 
phosphatase 
7295_at YBR072W HSP26  organization of cytoplasm; 
nuclear organization 
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response     
P -4.4 heat shock protein 26 
5595_at YER110C KAP123 YRB4; GIN1 organization of cytoplasm; 
nuclear organization  
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - nuclear 
transport / PROTEIN DESTINATION protein 
targeting, sorting and translocation  
P 2.0 Karyopherin beta 4 
8387_at YOR185C GSP2 (SSP101); 
CNR2 
organization of cytoplasm; 
nuclear organization   
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - nuclear 
transport / TRANSCRIPTION - RNA transport 
P -2.0  GTP binding protein, almost 
identical to Gsp1p  
7752_at YPL001W HAT1  organization of cytoplasm; 
nuclear organization    
PROTEIN DESTINATION - protein 
modification 
P 2.8 histone acetyltransferase 
10634_at YKL062W MSN4  organization of cytoplasm; 
nuclear organization     
METABOLISM - C-compound and 
carbohydrate metabolism; regulation of C-
compound and carbohydrate utilization 
/TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / CELL 
RESCUE, DEFENSE, CELL DEATH AND 
AGEING - stress response 
P -2.8 zinc finger protein 
3941_at YCL024W KCC4  organization of cytoskeleton CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -cell cycle control and mitosis    
P -2.5 Ser\/Thr protein kinase 
4765_at YGR245C SDA1  organization of cytoskeleton   P 2.5 similarity to hypothetical S.pombe 
protein 
9637_at YMR015C ERG5  organization of endoplasmatic 
reticulum 
METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism 
P 2.7 cytochrome P450 involved in C-22 
denaturation of the ergosterol side-
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6924_at YCL052C PBN1  organization of endoplasmatic 
reticulum  
PROTEIN DESTINATION - protein 
modification 
P -2.3 Protease B Non-derepressible 
8264_at YOR288C MPD1  organization of endoplasmatic 
reticulum  
PROTEIN DESTINATION - protein folding and 
stabilization 
P -2.1 Disulfide isomerase related protein 
6816_at YCR075C ERS1  organization of endoplasmatic 
reticulum  
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - other 
intracellular-transport activities/PROTEIN 
DESTINATION - protein targeting, sorting and 
translocation 
P -2.1 ERS1 protein, ER defect supressor  
3940_at YBR201W DER1  organization of endoplasmatic 
reticulum  
PROTEIN DESTINATION - proteolysis;other 
proteolytic degradation 
A ~-2.5 Degradation in the Endoplasmic 
Reticulum 
9635_at YMR013C SEC59  organization of endoplasmatic 
reticulum   
METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and isoprenoid 
utilization /CELL GROWTH, CELL DIVISION 
AND DNA SYNTHESIS - sporulation and 
germination 
P -2.8 membrane protein required for core 
glycosylation 
10275_at YLR066W SPC3  organization of endoplasmatic 
reticulum   
PROTEIN DESTINATION - protein 
modification 
P -2.1 signal peptidase subunit 
9724_at YML075C HMG1  organization of endoplasmatic 
reticulum   
METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and isoprenoid 
biosynthesis 
P 2.8 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) reductase 
isozyme 
5681_at YER026C CHO1 PSS1; PSS organization of endoplasmatic reticulum; mitochondrial organization; other 
cellular organization   
P 2.0 phosphatidylserine synthase 
6190_at YDR270W CCC2  organization of Golgi TRANSPORT FACILITATION - ion 
transporters, metal ion transporters, transport 
ATPases/ IONIC HOMEOSTASIS - 
homeostasis of cations, homeostasis of metal 
ions 
P 2.6 Copper-transporting P-type ATPase 
with similarity to human Menkes and 
Wilsons genes 
6099_at YDR358W GGA1  organization of Golgi  P -2.5 strong similarity to hypothetical 
protein YHR108w and weak 
similarity to signal transducing 
adaptor from mouse and man 
5024_at YGL038C OCH1  organization of Golgi   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /PROTEIN 
DESTINATION - protein modification 
P -2.4 membrane-bound 
mannosyltransferase 
5746_at YER001W MNN1  organization of Golgi   METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /PROTEIN 
DESTINATION - protein modification / 
P -2.1  Alpha-1,3-mannosyltransferase  
 CELLULAR ORGANIZATION     
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8802_at YNR044W AGA1  organization of plasma 
membrane 
CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -pheromone response, mating-
type, determination, sex-specific proteins    
P 2.0 anchorage subunit of a-agglutinin 
11026_at YJR004C SAG1  organization of plasma 
membrane 
CELL GROWTH, CELL DIVISION AND DNA 
SYNTHESIS -pheromone response, mating-
type determination, sex-specific proteins  
P 2.3 alpha-agglutinin 
5074_at YGL077C HNM1 CTR; HNM1; 
(CTR1) 
organization of plasma 
membrane  
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular import / 
TRANSPORT FACILITATION - amino-acid 
transporters  
P 2.2 Transporter (permease) for choline 
and nitrogen mustard\; share 
homology with UGA4 
4936_at YGR055W MUP1   organization of plasma 
membrane  
METABOLISM - amino-acid metabolism 
;amino-acid biosynthesis; amino-acid transport 
/TRANSPORT FACILITATION - amino-acid 
transporters; CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular import  
P 2.5 high affinity methionine permease 
6793_at YCR098C GIT1  organization of plasma 
membrane   
METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism; lipid and fatty-acid transport / 
TRANSPORT FACILITATION - lipid 
transporters 
P -49.0 permease involved in the uptake of 
glycerophosphoinositol (GroPIns) 
10106_at YLR214W FRE1  organization of plasma 
membrane   
IONIC HOMEOSTASIS - homeostasis of 
cations; homeostasis of other cations 
P 2.0 Ferric (and cupric) reductase 
4430_at YHR094C HXT1  organization of plasma 
membrane   
METABOLISM - C-compound and 
carbohydrate metabolism; C-compound, 
carbohydrate transport /TRANSPORT 
FACILITATION - C-compound and 
carbohydrate transporters / CELLULAR 
TRANSPORT AND 
TRANSPORTMECHANISMS  -  cellular import 
P 3.5 High-affinity hexose (glucose) 
transporter 
5669_g_at YER056C FCY2 BRA7 organization of plasma 
membrane    
METABOLISM - nucleotide metabolism; 
regulation of nucleotide metabolism; nucleotide 
transport /TRANSPORT FACILITATION - 
purine and pyrimidine transporters / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular import 
P 2.0 purine-cytosine permease 
9588_at YMR058W FET3  organization of plasma 
membrane    
TRANSPORT FACILITATION  - ion 
transporters; metal ion transporters (Cu, Fe, 
etc.) / CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular import / 
IONIC HOMEOSTASIS - homeostasis of 
cations; homeostasis of metal ions 
P 3.8 multicopper oxidase 
9762_at YML123C PHO84  organization of plasma 
membrane     
METABOLISM - phosphate metabolism; 
phosphate transport /IONIC HOMEOSTASIS - 
P -11.8  inorganic phosphate transporter, 
transmembrane protein  
 CELLULAR ORGANIZATION     
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homeostasis of cations; homeostasis of 
protons/ IONIC HOMEOSTASIS - homeostasis 
of anions; homeostasis of phosphate 
/TRANSPORT FACILITATION - ion 
transporters; anion transporters (Cl, SO4, PO4, 
etc.) /TRANSPORT FACILITATION - C-
compound and carbohydrate transporters / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular import 
5668_at YER056C FCY2 BRA7 organization of plasma 
membrane     
METABOLISM - nucleotide metabolism; 
regulation of nucleotide metabolism; nucleotide 
transport /TRANSPORT FACILITATION - 
purine and pyrimidine transporters / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular import 
P 2.1 purine-cytosine permease 
8400_at YOR153W PDR5 (STS1); 
YDR1; LEM 
organization of plasma 
membrane     
METABOLISM - lipid, fatty-acid and isoprenoid 
metabolism, lipid and fatty-acid transport 
/IONIC HOMEOSTASIS - homeostasis of 
cations; homeostasis of metal ions / 
TRANSPORT FACILITATION - ion 
transporters; other cation transporters (Na, K, 
Ca , NH4, etc.); ABC transporters / CELL 
RESCUE, DEFENSE, CELL DEATH AND 
AGEING - detoxificaton 
P 3.5 multidrug resistance transporter 
8959_at YNL117W MLS1  peroxisomal organization METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization / ENERGY - glyoxylate 
cycle 
A -3.4 carbon-catabolite sensitive malate 
synthase 
9057_at YNL202W SPS19 SPX19 peroxisomal organization  ENERGY - oxidation of fatty acids A -2.3  peroxisomal 2,4-dienoyl-CoA 
reductase  
8509_at YOR036W PEP12  VPL6;VPT13;
VPS6 
vacuolar and lysosomal 
organization 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS  - vacuolar 
transport / PROTEIN DESTINATION - protein 
targeting, sorting and translocation  
P -2.4 integral membrane protein\; c-
terminal TMD\; located in endosome 
7733_at YPR026W ATH1  vacuolar and lysosomal 
organization  
METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
carbohydrate utilization /ENERGY - 
metabolism of energy reserves (glycogen, 
trehalose)/ CELL RESCUE, DEFENSE, CELL 
DEATH AND AGEING - stress response 
A -3.2  null mutant is viable\; increased 
tolerance to dehydration, freezing, 
and toxic levels of ethanol  
5179_at YGL156W AMS1  vacuolar and lysosomal 
organization  
METABOLISM - C-compound and 
carbohydrate metabolism; C-compound and 
P -2.1 vacuolar alpha mannosidase 
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carbohydrate utilization 
10681_at YKL103C  APE1; YSC1 vacuolar and lysosomal 
organization   
PROTEIN DESTINATION - proteolysis; 
lysosomal and vacuolar degradation 
P -3.3 vacuolar aminopeptidase ysc1 
5995_at YDR481C PHO8  vacuolar and lysosomal organization   P -2.4 repressible alkaline phosphatase 
5774_at YEL060C PRB1 CVT1 vacuolar and lysosomal 
organization   
PROTEIN DESTINATION - protein 
modification; proteolysis; lysosomal and 
vacuolar degradation 
P -2.1 vacuolar protease B 
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10015_at YLR300W EXG1 BGL1 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
CELL GROWTH, CELL DIVISION AND 
DNA SYNTHESIS - cell growth; pheromone 
response, mating-type determination, sex-
specific proteins; sporulation and 
germination / CELLULAR ORGANIZATION 
- extracellular/secretion proteins   
P -2.0  Exo-1,3-beta-glucanase  
10019_at YLR304C ACO1 GLU1 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - tricarboxylic-acid pathway; 
glyoxylate cycle / CELLULAR 
ORGANIZATION  - organization of 
cytoplasm; mitochondrial organization   
P -4.8  Aconitase, mitochondrial  
10160_at YLR180W SAM1 ETH10 amino-acid metabolism; amino-acid 
biosynthesis; amino-acid 
degradation (catabolism)    
 P 3.1 S-adenosylmethionine 
synthetase 
10331_at YLL012W   lipid, fatty-acid and isoprenoid 
metabolism; breakdown of lipids, 
fatty acids and isoprenoids 
 P 2.5 similarity to triacylglycerol 
lipases 
10478_at YKR097W PCK1 PEPC; 
PPC1; 
JPM2 
C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization    
ENERGY - glycolysis and gluconeogenesis 
/ CELLULAR ORGANIZATION - 
organization of cytoplasm 
P -9.7 phosphoenolpyruvate 
carboxylkinase 
10480_at YKR099W BAS1  amino-acid metabolism; regulation 
of amino-acid 
metabolism;nucleotide metabolism; 
regulation of nucleotide metabolism  
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization       
P 2.4 Transcription factor regulating 
basal and induced activity of 
histidine and adenine 
biosynthesis genes 
10617_at YKL035W UGP1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) / PROTEIN 
DESTINATION - protein modification  
P -2.2 Uridinephosphoglucose 
pyrophosphorylase 
10629_at YKL067W YNK1 YNK;NDK1 nucleotide metabolism; other CELLULAR ORGANIZATION - P -2.4 Nucleoside diphosphate kinase 
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nucleotide-metabolism activities organization of cytoplasm  
10634_at YKL062W MSN4  C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response / 
CELLULAR ORGANIZATION - 
organization of cytoplasm; nuclear 
organization     
P -2.8 zinc finger protein 
10654_at YKL085W MDH1  C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate utilization 
ENERGY -tricarboxylic-acid pathway/ 
CELLULAR ORGANIZATION - 
mitochondrial organization 
P -2.6 mitochondrial malate 
dehydrogenase 
10725_at YKL148C SDH1 SDHA C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - tricarboxylic-acid pathway / 
CELLULAR ORGANIZATION - 
mitochondrial organization  
P -3.6 flavoprotein subunit of 
succinate dehydrogenase 
10795_at YKL217W JEN1  C-compound and carbohydrate 
metabolism; C-compound, 
carbohydrate transport  
TRANSPORT FACILITATION - C-
compound and carbohydrate transporters   
A ~-6.0 carboxylic acid transporter 
protein homolog 
10890_at YJR142W   metabolism of vitamins, cofactors, 
and prosthetic groups; biosynthesis 
of vitamins, cofactors, and 
prosthetic groups 
 P -2.6 similarity to thiamin 
pyrophosphokinase 
10935_at YJR096W   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
 P -2.5  similarity to Corynebacterium 
2,5-diketo-D-gluconic acid 
reductase and aldehyde 
reductases  
11097_at YJL060W   nitrogen and sulphur metabolism; 
nitrogen and sulphur utilization   
 P -2.8 similarity to kynurenine 
aminotransferase and 
glutamine-phenylpyruvate 
transaminase 
11262_s_at YAR071W PHO11  phosphate metabolism; phosphate 
utilization 
CELLULAR ORGANIZATION - 
extracellular/secretion proteins   
P -6.0  Acid phosphatase, secreted  
11379_at YAL067C SEO1  nitrogen and sulphur metabolism; 
nitrogen and sulphur transport 
TRANSPORT FACILITATION - other 
transport facilitators   
P ~3.0 Suppressor of Sulfoxyde 
Ethionine resistance 
11386_at YAL062W GDH3 FUN51 amino-acid metabolism; amino-acid 
degradation (catabolism); nitrogen 
and sulphur metabolism; nitrogen 
and sulphur utilization 
CELLULAR BIOGENESIS - biogenesis of 
cell wall (cell envelope)   
A ~-6.2 NADP-linked glutamate 
dehydrogenase 
11387_at YAL061W FUN50  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - fermentation  P -3.1 similarity to alcohol/sorbitol 
dehydrogenase 
3933_s_at MEL1 MEL1  C-compound and carbohydrate CELL GROWTH, CELL DIVISION AND P -2.9 Required for the catabolism of 
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metabolism; C-compound and 
carbohydrate utilization 
DNA SYNTHESIS - sporulation and 
germination  
melibiose and regulated by 
several GAL genes 
4100_at YIR019C MUC1 STA4; 
DEX2; 
MAL5; 
STA1; 
FLO11 
C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
CELLULAR ORGANIZATION - 
organization of cell wall; 
extracellular/secretion proteins   
P 7.2 cell surface flocculin with 
structure similar to 
serine\/threonine-rich GPI-
anchored cell wall proteins 
4118_at YIL009W FAA3  lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid biosynthesis; lipid, fatty-
acid and isoprenoid utilization   
 P 2.0 Acyl CoA synthase 
4126_at YIL045W PIG2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose)    
P -3.1 Protein with 30\%% identity to 
protein corresponding to 
YER054 
4231_at YIL125W KGD1 OGD1 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - tricarboxylic-acid pathway / 
CELLULAR ORGANIZATION - 
mitochondrial organization   
P -3.3 alpha-ketoglutarate 
dehydrogenase 
4232_at YIL124W AYR1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
CELL GROWTH, CELL DIVISION AND 
DNA SYNTHESIS - sporulation and 
germination   
P -2.8 similarity to C.perfringens 
nanH protein 
4246_at YIL155C GUT2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
CELLULAR ORGANIZATION - 
mitochondrial organization   
P -3.1  glycerol-3-phosphate 
dehydrogenase, mitochondrial  
4430_at YHR094C HXT1  C-compound and carbohydrate 
metabolism; C-compound, 
carbohydrate transport 
TRANSPORT FACILITATION - C-
compound and carbohydrate transporters / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS  -  cellular 
import / CELLULAR ORGANIZATION - 
organization of plasma membrane   
P 3.5 High-affinity hexose (glucose) 
transporter 
4442_at YHR104W GRE3  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response  
P -2.2 Aldo-keto reductase 
4476_at YHR047C AAP1'  C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) 
P 2.1 arginine\/alanine 
aminopeptidase 
4507_at YHR033W   amino-acidmetabolism; amino-acid 
biosynthesis 
 P -2.6 Pro1p (Gamma-glutamyl 
kinase) 
4542_at YHL020C OPI1  lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-
acid and isoprenoid biosynthesis 
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization    
P 2.0 negative regulator of 
phospholipid biosynthesis 
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4719_at YGR289C MAL11 AGT1 C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate transport 
TRANSPORT FACILITATION - C-
compound and carbohydrate transporters  
P -2.5 alpha-glucoside transporter 
4732_at YGR256W GND2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - pentose-phosphate pathway   A ~-8.3 6-phosphogluconate 
dehydrogenase 
4753_at YGR233C PHO81  phosphate metabolism; regulation of 
phosphate utilization   
 P -2.2 Positive regulatory protein of 
phosphate pathway 
4764_at YGR244C LSC2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - tricarboxylic-acid pathway   P -2.1 Succinate-CoA Ligase (ADP-
Forming) 
4804_at YGR194C XKS1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
 P -4.5 xylulokinase 
4818_at YGR208W SER2 PSP; LST3 amino-acid metabolism; amino-acid 
biosynthesis   
 P 2.1 phosphoserine phosphatase 
4832_at YGR177C ATF2  C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate utilization 
 P 2.7 Alcohol acetyltransferase 
4844_at YGR144W THI4 ESP35; 
MOL1 
metabolism of vitamins, cofactors, 
and prosthetic groups; other vitamin, 
cofactor, and prosthetic group 
activities 
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - DNA repair  
P ~3.4 component of the biosynthetic 
pathway producing the thiazole 
precursor of thiamine 
4856_at YGR155W CYS4 STR4; 
NHS5; 
VMA41 
amino-acid metabolism; amino-acid 
biosynthesis   
 P 2.1 Cystathionine beta-synthase 
4936_at YGR055W MUP1   amino-acid metabolism ;amino-acid 
biosynthesis; amino-acid transport 
TRANSPORT FACILITATION - amino-acid 
transporters; CELLULAR TRANSPORT 
AND TRANSPORTMECHANISMS - 
cellular import / CELLULAR 
ORGANIZATION - organization of plasma 
membrane  
P 2.5 high affinity methionine 
permease 
5024_at YGL038C OCH1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
PROTEIN DESTINATION - protein 
modification / CELLULAR ORGANIZATION 
- organization of Golgi   
P -2.4 membrane-bound 
mannosyltransferase 
5093_at YGL104C   C-compound and carbohydrate 
metabolism; C-compound, 
carbohydrate transport 
TRANSPORT FACILITATION - C-
compound and carbohydrate transporters  
P -2.8 similarity to glucose transport 
proteins 
5173_at YGL162W SUT1 STO1 lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-
acid and isoprenoid biosynthesis 
 P 3.1 Involved in sterol uptake 
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5179_at YGL156W AMS1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
CELLULAR ORGANIZATION - vacuolar 
and lysosomal organization  
P -2.1 vacuolar alpha mannosidase 
5194_at YGL186C   nucleotide metabolism; nucleotide 
transport  
TRANSPORT FACILITATION - purine and 
pyrimidine transporters   
P 2.0 similarity to hypothetical 
protein Fcy21p and weak 
similarity to FCY2 protein 
5216_at YGL209W MIG2 MLZ1 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control 
P 4.1 Protein containing zinc fingers 
very similar to zinc fingers in 
Mig1p 
5307_at YFR053C HXK1 HKA C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - glycolysis and gluconeogenesis 
/CELLULAR ORGANIZATION - 
organization of cytoplasm   
P -2.1 Hexokinase I (PI) (also called 
Hexokinase A) 
5357_at YFR015C GSY1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen,trehalose) /CELLULAR 
ORGANIZATION - organization of 
cytoplasm   
P -30.4 Glycogen synthase (UDP-
gluocse--starch 
glucosyltransferase) 
5372_at YFL014W HSP12 GLP1 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization; lipid, fatty-
acid and isoprenoid metabolism; 
lipid, fatty-acid and isoprenoid 
utilization 
CELLULAR COMMUNICATION/SIGNAL 
TRANSDUCTION - intracellular 
communication; osmosensing; other 
osmosensing activities / CELL RESCUE, 
DEFENSE, CELL DEATH AND AGEING - 
stress response; DNA repair   
P -9.4 12 kDa heat shock protein 
5400_at YFL030W   amino-acid metabolism; amino-acid 
biosynthesis; amino-acid 
degradation (catabolism); nitrogen 
and sulphur metabolism; nitrogen 
and sulphur utilization     
 P -8.2 similarity to several 
transaminases 
5409_at YFL021W GAT1 NIL1 nitrogen and sulphur metabolism; 
regulation of nitrogen and sulphur 
utilization  
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization     
P -2.1 transcriptional activator with 
GATA-1-type Zn finger DNA-
binding motif 
5428_at YFL052W   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis;transcriptional control 
P -2.5  strong similarity to Mal63p, 
YPR196w and Mal13p  
5633_at YER062C HOR2  GPP2 C-compound and carbohydrate 
metabolism;C-compound and 
carbohydrate utilization  
 P -2.5 DL-glycerol-3-phosphatase 
5665_at YER053C   phosphate metabolism; phosphate 
transport 
IONIC HOMEOSTASIS / TRANSPORT 
FACILITATION - ion transporters; anion 
transporters / CELLULAR TRANSPORT 
AND TRANSPORTMECHANISMS - 
mitochondrial transport    
P -3.0 strong similarity to 
mitochondrial phosphate 
carrier protein 
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5666_at YER054C GIP2  C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) 
P -2.1  Glc7-interacting protein\; 
shares homology with PIG2\; 
contains conserved 25 residue 
motif, called the GVNK motif, 
also found in GAC1, PIG1, 
PIG2, and RGI, the 
mammalian type 1 
phosphatase targeting subunit.  
5668_at YER056C FCY2 BRA7 nucleotide metabolism; regulation of 
nucleotide metabolism; nucleotide 
transport 
TRANSPORT FACILITATION - purine and 
pyrimidine transporters / CELLULAR 
TRANSPORT AND 
TRANSPORTMECHANISMS - cellular 
import/ CELLULAR ORGANIZATION - 
organization of plasma membrane     
P 2.1 purine-cytosine permease 
5669_g_at YER056C FCY2 BRA7 nucleotide metabolism; regulation of 
nucleotide metabolism; nucleotide 
transport  
TRANSPORT FACILITATION - purine and 
pyrimidine transporters / CELLULAR 
TRANSPORT AND 
TRANSPORTMECHANISMS - cellular 
import / CELLULAR ORGANIZATION - 
organization of plasma membrane    
P 2.0 purine-cytosine permease 
5697_at YER042W MXR1 MSRA amino-acid metabolism; other 
amino-acid metabolism activities  
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - stress response  
P 2.4 responsible for the reduction of 
methionine sulfoxide 
5702_at YER003C PMI40  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
CELLULAR ORGANIZATION - 
organization of cytoplasm   
P -2.1 mannose-6-phosphate 
isomerase 
5714_at YER014W HEM14  metabolism of vitamins, cofactors, 
and prosthetic groups; biosynthesis 
of vitamins, cofactors, and 
prosthetic groups  
CELLULAR ORGANIZATION - 
mitochondrial organization 
P -2.0 protoporphyrinogen oxidase 
5735_at YEL011W GLC3  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) / CELLULAR 
ORGANIZATION - organization of 
cytoplasm   
P -8.3  1,4-glucan-6-(1,4-glucano)-
transferase  
5746_at YER001W MNN1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
PROTEIN DESTINATION - protein 
modification /CELLULAR ORGANIZATION 
- organization of Golgi   
P -2.1  Alpha-1,3-
mannosyltransferase  
5940_at YDR516C   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
 P -2.4 strong similarity to glucokinase 
5972_at YDR503C LPP1 ScPAP2 lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-
acid and isoprenoid biosynthesis 
 P -3.4 Lipid phosphate phosphatase 
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6082_at YDR384C   C-compound and carbohydrate 
metabolism;  C-compound and 
carbohydrate utilization 
ENERGY - other energy generation 
activities   
P 5.4 strong similarity to Y.lipolytica 
GPR1 gene 
6192_at YDR272W GLO2  amino-acid metabolism; amino-acid 
degradation (catabolism) 
CELLULAR ORGANIZATION - 
organization of cytoplasm    
P -2.0 Cytoplasmic glyoxylase-II 
6273_at YDR216W ADR1  C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization    
P -5.8 positive transcriptional 
regulator of ADH2 and 
peroxisomal protein genes 
6279_at YDR178W SDH4  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - tricarboxylic-acid pathway; 
respiration/ CELLULAR ORGANIZATION  - 
mitochondrial organization   
P -4.1 succinate dehydrogenase 
membrane anchor subunit 
6339_at YDR148C KGD2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - tricarboxylic-acid pathway / 
CELLULAR ORGANIZATION - 
mitochondrial organization   
P -3.0 dihydrolipoyl transsuccinylase 
component of alpha-
ketoglutarate dehydrogenase 
complex in mitochondria 
6358_at YDR123C INO2 (SCS1); 
DIE1 
lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-
acid and isoprenoid biosynthesis 
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization     
P 5.6 helix-loop-helix protein 
6398_at YDR074W TPS2 HOG2; 
PFK3 
C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) / CELL RESCUE, 
DEFENSE, CELL DEATH AND AGEING - 
stress response / CELLULAR 
ORGANIZATION - organization of 
cytoplasm; mitochondrial organization   
P -3.9 Trehalose-6-phosphate 
phosphatase 
6462_at YDR001C NTH1 NTH;YD811
9.07 
C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate utilization 
ENERGY -metabolism of energy reserves 
(glycogen, trehalose)/CELLULAR 
ORGANIZATION - organization of 
cytoplasm 
P -2.7  neutral trehalase (alpha,alpha-
trehalase)  
6486_at YDL021W GPM2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - glycolysis and gluconeogenesis  P -6.4 Similar to GPM1 
(phosphoglycerate mutase) 
6515_at YDL037C   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
 P 9.0  strong similarity to glucan 1,4-
alpha-glucosidase  
6577_at YDL109C   lipid, fatty-acid and isoprenoid 
metabolism ; breakdown of lipids, 
fatty acids and isoprenoids 
 P 2.6 strong similarity to thiamine-
repressed protein Thi4p 
6607_at YDL124W   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
 P -2.0 similarity to aldose reductases 
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6633_at YDL142C CRD1 CLS1; 
(PGS1) 
lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid biosynthesis   
 P -2.3 Cardiolipin synthase 
6793_at YCR098C GIT1  lipid, fatty-acid and isoprenoid 
metabolism; lipid and fatty-acid 
transport 
TRANSPORT FACILITATION - lipid 
transporters / CELLULAR ORGANIZATION 
- organization of plasma membrane   
P -49.0 permease involved in the 
uptake of 
glycerophosphoinositol 
(GroPIns) 
6827_at YCR037C PHO87  phosphate metabolism; phosphate 
transport  
IONIC HOMEOSTASIS - homeostasis of 
anions; homeostasis of phosphate / 
TRANSPORT FACILITATION - ion 
transporters; anion transporters (Cl, SO4, 
PO4, etc.)     
P 2.1 May collaborate with Pho86p 
and Pho84p in inorganic 
phosphate uptake\; protein 
contains 12 predicted 
transmembrane domains 
6937_at YCL040W GLK1                                                  
SCAN11 
C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate utilization 
ENERGY - glycolysis and 
gluconeogenesis/CELLULAR 
ORGANIZATION - organization of 
cytoplasm 
P -2.7 Glucokinase 
7072_s_at YBR299W MAL32 MAL3S C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization   
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) 
P -4.1 Maltase (EC 3.2.1.20) 
7106_at YBR241C   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate transport 
TRANSPORT FACILITATION- C-
compound and carbohydrate transporters 
P -2.6 Probable sugar transport 
protein 
7195_at YBR149W ARA1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
 P -3.6 D-arabinose dehydrogenase 
7217_at YBR126C TPS1 GGS1; 
CIF1; TSS1; 
FDP1; 
BYP1; 
GLC6 
C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization; regulation 
of C-compound and carbohydrate 
utilization  
ENERGY - metabolism of energy reserves 
(glycogen,  trehalose) /  CELL RESCUE, 
DEFENSE, CELL DEATH AND AGEING  - 
stress response / CELLULAR 
ORGANIZATION - organization of 
cytoplasm 
P -2.9 56 kD synthase subunit of 
trehalose-6-phosphate 
synthase\/phosphatase 
complex 
7273_at YBR092C PHO3  phosphate metabolism; phosphate 
utilization; metabolism of vitamins, 
cofactors, and prosthetic groups; 
utilization of vitamins, cofactors, and 
prosthetic groups 
CELLULAR ORGANIZATION - 
extracellular/secretion proteins    
P -25.6  Acid phosphatase, constitutive 
7274_at YBR093C PHO5  phosphate metabolism; phosphate 
utilization; metabolism of vitamins, 
cofactors, and prosthetic groups; 
utilization of vitamins, cofactors, and 
prosthetic groups 
CELLULAR ORGANIZATION - 
organization of cell wall  
P -21.4  Acid phosphatase, repressible  
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7324_at YBR056W   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
 P -4.8  Homolog to glucan-1,3--
glucosidase (EC 3.2.1.5\; S. 
cerevisiae) 2  
7361_at YBR001C NTH2  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose)  
P -4.7  Neutral trehalase, highly 
homologous to Nth1p  
7392_at YBL015W ACH1  lipid, fatty-acid and isoprenoid 
metabolism; regulation of lipid, fatty-
acid and isoprenoid biosynthesis 
CELL GROWTH, CELL DIVISION AND 
DNA SYNTHESIS - sporulation and 
germination / CELLULAR ORGANIZATION 
- organization of cytoplasm  
P -7.1 acetyl CoA hydrolase 
7582_at YPR184W GDB1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose)   
P -5.6  similarity to human 4-alpha-
glucanotransferase (EC 
2.4.1.25)/amylo-1,6-
glucosidase (EC 3.2.1.33)  
7604_at YPR160W GPH1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) / CELLULAR 
ORGANIZATION - organization of 
cytoplasm    
P -10.9 Glycogen phosphorylase 
7685_at YPR065W ROX1 REO1 metabolism of vitamins, cofactors, 
and prosthetic groups 
TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization    
P 6.1  site-specific DNA binding 
protein, repressor  
7733_at YPR026W ATH1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose)/ CELL RESCUE, 
DEFENSE, CELL DEATH AND AGEING - 
stress response / CELLULAR 
ORGANIZATION - vacuolar and lysosomal 
organization  
A -3.2  null mutant is viable\; 
increased tolerance to 
dehydration, freezing, and 
toxic levels of ethanol  
7767_at YPL031C PHO85  phosphate metabolism; regulation of 
phosphate utilization; C-compound 
and carbohydrate metabolism; 
regulation of C-compound and 
carbohydrate utilization  
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) / CELL GROWTH, 
CELL DIVISION AND DNA SYNTHESIS - 
cell cycle control and mitosis 
/TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization       
P -2.1  negative transcriptional 
regulator, protein kinase 
homolog  
7869_at YPL111W CAR1  amino-acid metabolism; amino-acid 
degradation (catabolism); nitrogen 
and sulphur metabolism; regulation 
of nitrogen and sulphur utilization 
CELLULAR ORGANIZATION - 
organization of cytoplasm   
P 2.1 arginase 
7890_at YPL135W ISU1  nitrogen and sulphur metabolism; 
nitrogen and sulphur utilization   
 P 3.0 NifU-like protein A 
 CELLULAR ORGANIZATION     
     
  
25 
8151_s_at YOR074C  CDC21 TMP1 nucleotide metabolism, 
deoxyribonucleotide metabolism 
CELLULAR ORGANIZATION - nuclear 
organization 
P -2.7 Thymidylate synthase 
8380_at YOR178C GAC1  C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
ENERGY - metabolism of energy reserves 
(glycogen, trehalose)/ CELLULAR 
ORGANIZATION - organization of 
cytoplasm     
P -4.8 Regulatory subunit for Glc7p 
8389_at YOR142W LSC1 PSC4 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - tricarboxylic-acid pathway   P -2.1 Succinate-CoA Ligase (ADP-
Forming) 
8400_at YOR153W PDR5 (STS1); 
YDR1; LEM 
lipid, fatty-acid and isoprenoid 
metabolism, lipid and fatty-acid 
transport 
IONIC HOMEOSTASIS - homeostasis of 
cations; homeostasis of metal ions / 
TRANSPORT FACILITATION - ion 
transporters; other cation transporters (Na, 
K, Ca , NH4, etc.); ABC transporters / 
CELL RESCUE, DEFENSE, CELL DEATH 
AND AGEING - detoxificaton/ CELLULAR 
ORGANIZATION - organization of plasma 
membrane     
P 3.5 multidrug resistance 
transporter 
8428_at YOR136W IDH2  C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate utilization 
ENERGY - tricarboxylic-acid 
pathway/TRANSCRIPTION - other 
transcription activities/CELLULAR 
ORGANIZATION - mitochondrial 
organization 
P -2.7 NAD+-dependent isocitrate 
dehydrogenase 
8593_at YOL058W ARG1 ARG10 amino-acid metabolism; amino-acid 
biosynthesis; nitrogen and sulphur 
metabolism; nitrogen and sulphur 
utilization 
CELLULAR ORGANIZATION - 
organization of cytoplasm     
P -2.1 arginosuccinate synthetase 
8632_at YOL065C INP54  lipid, fatty-acid and isoprenoid 
metabolism; other lipid, fatty-acid 
and isoprenoid metabolism activities  
 P -2.2 inositol polyphosphate 5-
phosphatase 
8849_at YNR001C CIT1 LYS6; 
GLU3 
C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - tricarboxylic-acid pathway/ 
CELLULAR ORGANIZATION - 
mitochondrial organization    
P -4.3 citrate synthase. Nuclear 
encoded mitochondrial protein. 
8860_at YNR012W URK1  nucleotide metabolism; pyrimidine-
ribonucleotide metabolism   
 P 2.4 Uridine kinase 
8867_at YNR019W ARE2 SAT1 lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid biosynthesis 
CELL GROWTH, CELL DIVISION AND 
DNA SYNTHESIS - sporulation and 
germination   
P 5.9 Acyl-CoA cholesterol 
acyltransferase (sterol-ester 
synthetase) 
8959_at YNL117W MLS1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - glyoxylate cycle/ CELLULAR 
ORGANIZATION - peroxisomal 
organization  
A -3.4 carbon-catabolite sensitive 
malate synthase 
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8966_at YNL111C CYB5  lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid biosynthesis  
 P 4.1 cytochrome b5 
9027_at YNL141W AAH1  nucleotide metabolism; purine-
ribonucleotide metabolism   
 P 2.3 Adenosine 
deaminase\/adenine 
aminohydrolase 
9120_at YNL274C   C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization   
 A -6.1 similarity to glycerate- and 
formate-dehydrogenases 
9329_at YMR280C CAT8 DIL1; 
(MSP8) 
C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
ENERGY - glycolysis and gluconeogenesis 
/ TRANSCRIPTION - mRNA transcription; 
mRNA synthesis; transcriptional control / 
CELLULAR ORGANIZATION - nuclear 
organization    
A ~-3.0 Zinc-cluster protein involved in 
activating gluconeogenic 
genes\; related to Gal4p 
9355_at YMR261C TPS3   C-compound and carbohydrate 
metabolism,C-compound and 
carbohydrate utilization 
ENERGY -metabolism of energy reserves 
(glycogen, trehalose)/CELLULAR 
ORGANIZATION - organization of 
cytoplasm 
P -2.6 115 kD regulatory subunit of 
trehalose-6-phosphate 
synthase\/phosphatase 
complex 
9388_at YMR250W GAD1  amino-acid metabolism; amino-acid 
biosynthesis  
 P -12.2 similarity to glutamate 
decarboxylases 
9547_at YMR105C PGM2 GAL5 C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose)/ CELLULAR 
ORGANIZATION - organization of 
cytoplasm   
P -8.3 Phosphoglucomutase 
9567_at YMR081C ISF1 MBR3 nucleotide metabolism; 
polynucleotide degradation   
 P -4.7  May regulate NAM7 function, 
possibly at level of mRNA 
turnover  
9586_at YMR056C AAC1 (ANC1) nucleotide metabolism; nucleotide 
transport 
TRANSPORT FACILITATION - purine and 
pyrimidine transporters /CELLULAR 
TRANSPORT AND 
TRANSPORTMECHANISMS - 
mitochondrial transport /CELLULAR 
ORGANIZATION - mitochondrial 
organization  
P -2.0 mitochondrial ADP\/ATP 
translocator 
9635_at YMR013C SEC59  lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid utilization 
CELL GROWTH, CELL DIVISION AND 
DNA SYNTHESIS - sporulation and 
germination / CELLULAR ORGANIZATION 
- organization of endoplasmatic reticulum   
P -2.8 membrane protein required for 
core glycosylation 
9637_at YMR015C ERG5  lipid, fatty-acid and isoprenoid 
metabolism 
CELLULAR ORGANIZATION - 
organization of endoplasmatic reticulum 
P 2.7 cytochrome P450 involved in 
C-22 denaturation of the 
ergosterol side-chain 
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9642_at YMR020W FMS1  lipid, fatty-acid and isoprenoid 
metabolism; lipid and fatty-acid 
binding   
 P -2.3  Multicopy suppressor of 
fenpropimorph resistance (fen2 
mutant), shows similarity to 
Candida albicans 
corticosteroid-binding protein 
CBP1  
9645_at YML019W OST6  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
PROTEIN DESTINATION - protein 
modification 
P -2.0 Putative new 37kDa subunit of 
N-oligosaccharyltransferase 
complex 
9668_at YML042W CAT2 YCAT,CAT lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid biosynthesis  
 P -2.5  Carnitine O-acetyltransferase, 
peroxisomal and mitochondrial  
9724_at YML075C HMG1  lipid, fatty-acid and isoprenoid 
metabolism; lipid, fatty-acid and 
isoprenoid biosynthesis 
CELLULAR ORGANIZATION - 
organization of endoplasmatic reticulum   
P 2.8 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) 
reductase isozyme 
9743_at YML100W TSL1  C-compound and carbohydrate 
metabolism;C-compound and 
carbohydrate utilization 
ENERGY - metabolism of energy reserves 
(glycogen, trehalose) / CELLULAR 
ORGANIZATION - organization of 
cytoplasm  
P -16.5 123 kD regulatory subunit of 
trehalose-6-phosphate 
synthase\/phosphatase 
complex\; homologous to 
TPS3 gene product 
9762_at YML123C PHO84  phosphate metabolism; phosphate 
transport 
IONIC HOMEOSTASIS - homeostasis of 
cations; homeostasis of protons/ IONIC 
HOMEOSTASIS - homeostasis of anions; 
homeostasis of phosphate /TRANSPORT 
FACILITATION - ion transporters; anion 
transporters (Cl, SO4, PO4, etc.) 
/TRANSPORT FACILITATION - C-
compound and carbohydrate transporters / 
CELLULAR TRANSPORT AND 
TRANSPORTMECHANISMS - cellular 
import /CELLULAR ORGANIZATION - 
organization of plasma membrane     
P -11.8  inorganic phosphate 
transporter, transmembrane 
protein  
9958_at YLR377C FBP1  C-compound and carbohydrate 
metabolism; C-compound and 
carbohydrate utilization  
ENERGY - glycolysis and gluconeogenesis 
/ CELLULAR ORGANIZATION - 
organization of cytoplasm  
A -3.9  fructose-1,6-bisphosphatase  
9969_at YLR345W   C-compound and carbohydrate 
metabolism; regulation of C-
compound and carbohydrate 
utilization  
ENERGY - glycolysis and gluconeogenesis  P -2.4 similarity to Pfk26p and other 
6-phosphofructo-2-kinases 
9980_at YLR359W ADE13 BRA1; 
BRA8 
nucleotide metabolism; purine-
ribonucleotide metabolism   
 P -4.2 similarity to SCM4 protein 
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